
维百奥生物可提供Absolute Antibody重组抗体。
【声明1】我司本网页所展示产品列表、Logo、图片、商标、品牌中英文名字,仅作为客观展示产品所用,如有侵权,请联系随时联系我司。
【声明2】我司不销售归类为危险品或其他违规品的产品,但由于本行业产品货号、型号众多,我司在发布时,难免遗漏,如在网页上显示某一货号或品名属于危险品或其他违规品,不代表我司倾向宣传或有意愿销售该产品;欢迎各界朋友批评指正,我们将立即改正。
【声明3】本网页所展示的品牌和产品,仅用于科学研究,不可用于人体、不可用于诊断或治疗。
Absolute Antibody以专注于提供基于DNA序列的工程化重组抗体而为人所知。公司由Hutchings博士和Barclay教授创办,总部位于英国剑桥,服务于全球65个国家的制药、生物技术和诊断公司及学术研究机构。作为唯一一家100%专注于重组抗体技术的公司,Absolute Antibody通过其HEXpress™专有平台,实现了两大核心创新:一是开发出专有的克隆系统,可将抗体快速重编为180多种格式,如双特异性抗体和Fc Silent™变体;二是针对科研痛点,推出了VivopureX™物种匹配抗体(减少体内实验背景)和Prometheus™服务(聚焦抗体的可制造性,已完成超过145个人源化项目)。其产品线涵盖超过15,000种工程化重组抗体及Fc融合蛋白目录,并提供从杂交瘤测序(已完成超5,000个杂交瘤测序)到重组表达的全链条定制服务。其产品氨基酸序列明确,不含动物成分,批次间一致性高,消除了传统抗体因补体和Fc受体造成的背景干扰,确保结果干净可重复。Absolute Antibody的生产设施已通过ISO 9001:2015认证,可在两周内提供100 mg级工程化重组抗体,已生产超过23,000种不同的重组抗体,总计1,000克蛋白。

❑ Absolute Antibody产品线
● 一抗:提供超过15,000种工程化重组抗体,靶点覆盖免疫肿瘤学、细胞生物学、神经科学及传染病等前沿领域。所有产品均采用重组技术生产,确保氨基酸序列明确、批次间稳定,并支持WB、IHC、IF、FCM等多种应用。
● 二抗:提供源自山羊或兔的多种重组抗免疫球蛋白二抗,特异性强、背景低,适用于蛋白免疫印迹、免疫组化、免疫荧光及流式细胞术等多种检测体系。
● 重组蛋白:提供包括Fc融合蛋白在内的高纯度重组蛋白,可用于体内外研究,改善蛋白稳定性和体内半衰期。同时提供研究级生物类似药(如曲妥珠单抗、西妥昔单抗等),支持药物机制研究和生物工艺开发。
● 定制抗体服务:提供从杂交瘤测序、抗体工程(人源化、嵌合化、Fc Silent™突变、双特异性等)到重组表达和偶联标记的全链条定制服务,支持毫克级到克级生产。
❑ Absolute Antibody产品列表
| 目录 | 品名 |
| Anti-Allergen Antibodies | Anti-11S globulin seed storage protein [X338] |
| Anti-Allergen Antibodies | Anti-11S globulin-like protein [X389] |
| Anti-Allergen Antibodies | Anti-Alliinase [X420] |
| Anti-Allergen Antibodies | Anti-Almond Allergen [X151] |
| Anti-Allergen Antibodies | Anti-Almond Allergen [X50] |
| Anti-Allergen Antibodies | Anti-Amphibian Allergen [X359] |
| Anti-Allergen Antibodies | Anti-Api m 2 [21E11] |
| Anti-Allergen Antibodies | Anti-Asp f 1 [14H4] |
| Anti-Allergen Antibodies | Anti-Asp f 1 [17A5] |
| Anti-Allergen Antibodies | Anti-Asp f 1 [4F8] |
| Anti-Allergen Antibodies | Anti-Asp f9 [5C6] |
| Anti-Allergen Antibodies | Anti-Bet v 1 [BAB2] |
| Anti-Allergen Antibodies | Anti-Bet v 1 [BAB3] |
| Anti-Allergen Antibodies | Anti-Bet v 1 [BAB4] |
| Anti-Allergen Antibodies | Anti-Bet v 1 [BAB5] |
| Anti-Allergen Antibodies | Anti-Bet v 1 [BV16] |
| Anti-Allergen Antibodies | Anti-Bet v 1 [H3-1] |
| Anti-Allergen Antibodies | Anti-Bet v 1 [M0418] |
| Anti-Allergen Antibodies | Anti-beta Lactoglobulin [XM28] |
| Anti-Allergen Antibodies | Anti-Bla g 1 [Bla g 1-scFv] |
| Anti-Allergen Antibodies | Anti-Bla g 2 [4C3] |
| Anti-Allergen Antibodies | Anti-Bla g 2 [7C11] |
| Anti-Allergen Antibodies | Anti-Bos d 5 [D1] |
| Anti-Allergen Antibodies | Anti-C3a Receptor [D098G01] |
| Anti-Allergen Antibodies | Anti-C3a Receptor [D1858G07] |
| Anti-Allergen Antibodies | Anti-Casein [X655] |
| Anti-Allergen Antibodies | Anti-Cashew Allergen [X467] |
| Anti-Allergen Antibodies | Anti-Celery Allergen [X474] |
| Anti-Allergen Antibodies | Anti-Coconut Allergen [X423] |
| Anti-Allergen Antibodies | Anti-Cod parvalbumin [X36] |
| Anti-Allergen Antibodies | Anti-Der f 1 [6A8] |
| Anti-Allergen Antibodies | Anti-Der p 1[10B9] |
| Anti-Allergen Antibodies | Anti-Der p 1[5H8] |
| Anti-Allergen Antibodies | Anti-Der p 1,Der f 1[4C1] |
| Anti-Allergen Antibodies | Anti-Der p 2 [H10] |
| Anti-Allergen Antibodies | Anti-Der p 2 [H5] |
| Anti-Allergen Antibodies | Anti-Der p 7 [WH9] |
| Anti-Allergen Antibodies | Anti-Fc epsilon R [IB10] |
| Anti-Allergen Antibodies | Anti-Fc epsilon R [IE7] |
| Anti-Allergen Antibodies | Anti-FceR1 alpha [Mar-1] |
| Anti-Allergen Antibodies | Anti-Fel d 1 [REGN1909] |
| Anti-Allergen Antibodies | Anti-Gliadin [1E01] |
| Anti-Allergen Antibodies | Anti-Gliadin [1E03] |
| Anti-Allergen Antibodies | Anti-Gliadin [PEE14C7] |
| Anti-Allergen Antibodies | Anti-Gliadin [VHH26] |
| Anti-Allergen Antibodies | Anti-Hev b 6.02 [G7] |
| Anti-Allergen Antibodies | Anti-Hev b 6.02 [H8] |
| Anti-Allergen Antibodies | Anti-Hev b 6.02 [M8] |
| Anti-Allergen Antibodies | Anti-IDO1 [19C5] |
| Anti-Allergen Antibodies | Anti-lgE [D9#3116] |
| Anti-Allergen Antibodies | Anti-lgE [huMaE11 (0malizumab)] |
| Anti-Allergen Antibodies | Anti-lgE [mAbA9] |
| Anti-Allergen Antibodies | Anti-lgE [TES-C21] |
| Anti-Allergen Antibodies | Anti-IL-12p40[Antibody80] |
| Anti-Allergen Antibodies | Anti-IL-1B[10A10] |
| Anti-Allergen Antibodies | Anti-IL-1B[1F3] |
| Anti-Allergen Antibodies | Anti-IL-1B [IC8] |
| Anti-Allergen Antibodies | Anti-IL-1B [MAb201] |
| Anti-Allergen Antibodies | Anti-IL-33[309h] |
| Anti-Allergen Antibodies | Anti-IL-33[874F7-Hu1] |
| Anti-Allergen Antibodies | Anti-IL-33[H02-8F11Hz01] |
| Anti-Allergen Antibodies | Anti-IL-33[W3759-cAb1] |
| Anti-Allergen Antibodies | Anti-Il-8[5.12.14] |
| Anti-Allergen Antibodies | Anti-IL-9 [MH9A4] |
| Anti-Allergen Antibodies | Anti-Lupin Allergen [X291] |
| Anti-Allergen Antibodies | Anti-Lysozyme [cAb-Lys3] |
| Anti-Allergen Antibodies | Anti-Lysozyme [D11.15] |
| Anti-Allergen Antibodies | Anti-Macadamia Allergen [X313] |
| Anti-Allergen Antibodies | Anti-Macadamia protein 2 [X327] |
| Anti-Allergen Antibodies | Anti-ovotransferrin [X183] |
| Anti-Allergen Antibodies | Anti-Pancreatic alpha- amylase [AMD9] |
| Anti-Allergen Antibodies | Anti-Peanut Allergen [X378] |
| Anti-Allergen Antibodies | Anti-Phl p 1 [Clone 10] |
| Anti-Allergen Antibodies | Anti-Phl p 1 [Clone 25] |
| Anti-Allergen Antibodies | Anti -Phl p 1 [Clone 43] |
| Anti-Allergen Antibodies | Anti-Phlp1[p1-20] |
| Anti-Allergen Antibodies | Anti-Phlp 11[p11-5] |
| Anti-Allergen Antibodies | Anti-Phlp2[p2-2] |
| Anti-Allergen Antibodies | Anti-Phlp 4 [p4-5] |
| Anti-Allergen Antibodies | Anti-Phlp5[4.2] |
| Anti-Allergen Antibodies | Anti-Phl p 5 [p5-11] |
| Anti-Allergen Antibodies | Anti-Phl p 6 [p6-1] |
| Anti-Allergen Antibodies | Anti-Soy Allergen [X259] |
| Anti-Allergen Antibodies | Anti-sST2[67186-15] |
| Anti-Allergen Antibodies | Anti-sST2 [67186-6] |
| Anti-Allergen Antibodies | Anti-ST2[C11] |
| Anti-Allergen Antibodies | Anti-ST2 [D12] |
| Anti-Allergen Antibodies | Anti-ST2L [CNTO3914 (C1999)] |
| Anti-Allergen Antibodies | Anti-ST2L [ST2M51] |
| Anti-Allergen Antibodies | Anti-ST2L [STLM208 (ST2H257)] |
| Anti-Allergen Antibodies | Anti-ST2L [STLM62 (C2494)] |
| Anti-Virus Antibodies | Anti- Fusion glycoprotein F0 [PIA174] |
| Anti-Virus Antibodies | Anti-3pk [3p-8-1] |
| Anti-Virus Antibodies | Anti-4-1BB [BBK2] |
| Anti-Virus Antibodies | Anti-A14 [BB5.2] |
| Anti-Virus Antibodies | Anti-A27L, Protein A27 [8E3] |
| Anti-Virus Antibodies | Anti-ACE2 [h11B11] |
| Anti-Virus Antibodies | Anti-ACE2 [h166D4] |
| Anti-Virus Antibodies | Anti-ASCL1 [SC72.2] |
| Anti-Virus Antibodies | Anti-avian infectious bronchitis virus Nucleoprotein [C5P1] |
| Anti-Virus Antibodies | Anti-Bordetella pertussis lipooligosaccharide [HBp2] |
| Anti-Virus Antibodies | Anti-Bovine Coronavirus [BCoV1/1] |
| Anti-Virus Antibodies | Anti-Bovine coronavirus [SF-3E4] |
| Anti-Virus Antibodies | Anti-Broad bean mottle virus [NbBBMV01] |
| Anti-Virus Antibodies | Anti-Canarypox Virus [CNPV-5A11] |
| Anti-Virus Antibodies | Anti-Canine distemper virus [1G5] |
| Anti-Virus Antibodies | Anti-Canine distemper virus [2G3] |
| Anti-Virus Antibodies | Anti-Canine distemper virus [6E11] |
| Anti-Virus Antibodies | Anti-Canine Parvovirus [scFv] |
| Anti-Virus Antibodies | Anti-Cap protein [Nb15] |
| Anti-Virus Antibodies | Anti-Cap, Capsid protein [3A5] |
| Anti-Virus Antibodies | Anti-Capsid protein [A6.2] |
| Anti-Virus Antibodies | Anti-Capsid protein VP25 [PL-2 scFv] |
| Anti-Virus Antibodies | Anti-Capsid protein VP3 [VHH-12B] |
| Anti-Virus Antibodies | Anti-Capsid protein VP3 [VHH-7A] |
| Anti-Virus Antibodies | Anti-Capsid protein VP3 [VHH-7B] |
| Anti-Virus Antibodies | Anti-CCHFV NP protein [cAb4729 ] |
| Anti-Virus Antibodies | Anti-CCR5 [ST6] |
| Anti-Virus Antibodies | Anti-CD11b [BEAR1] |
| Anti-Virus Antibodies | Anti-CD205 [DEC-205] |
| Anti-Virus Antibodies | Anti-CD25 [7D4] |
| Anti-Virus Antibodies | Anti-CD4 [5A8] |
| Anti-Virus Antibodies | Anti-CD4 [EDU-2 (B486)] |
| Anti-Virus Antibodies | Anti-CD5 [OX-19] |
| Anti-Virus Antibodies | Anti-CD81 [CD81K04] |
| Anti-Virus Antibodies | Anti-Cedar virus F [19E 7] |
| Anti-Virus Antibodies | Anti-Cedar virus G [11D5] |
| Anti-Virus Antibodies | Anti-Cell surface-binding protein D8L [LA5] |
| Anti-Virus Antibodies | Anti-cFos [C1-82] |
| Anti-Virus Antibodies | Anti-cFos [C1-84] |
| Anti-Virus Antibodies | Anti-cFos [C2-58] |
| Anti-Virus Antibodies | Anti-cFos [C2-66] |
| Anti-Virus Antibodies | Anti-cFos [S1-54] |
| Anti-Virus Antibodies | Anti-cFos [S1-71] |
| Anti-Virus Antibodies | Anti-Citrus tristeza virus coat protein [3CA5] |
| Anti-Virus Antibodies | Anti-Citrus tristeza virus coat protein [3DF1] |
| Anti-Virus Antibodies | Anti-CMV [EIV-15] |
| Anti-Virus Antibodies | Anti-CMV coat protein [6A1] |
| Anti-Virus Antibodies | Anti-CMV glycoprotein gB [HCMV37] |
| Anti-Virus Antibodies | Anti-Coat protein [DDF-RuV1] |
| Anti-Virus Antibodies | Anti-Coat protein [DDF-RuV2] |
| Anti-Virus Antibodies | Anti-Coat protein [scFvB9] |
| Anti-Virus Antibodies | Anti-complete inactivated virus [Nb7] |
| Anti-Virus Antibodies | Anti-complete inactivated virus [Nb93] |
| Anti-Virus Antibodies | Anti-Covid-19 & SARS-CoV Nucleocapsid [1C7C7] |
| Anti-Virus Antibodies | Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] |
| Anti-Virus Antibodies | Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)] |
| Anti-Virus Antibodies | Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022] |
| Anti-Virus Antibodies | Anti-CPV capsid [A3B10 (MAb 8)] |
| Anti-Virus Antibodies | Anti-CPV capsid [Clone 2] |
| Anti-Virus Antibodies | Anti-CymMV Coat protein [11A12F5] |
| Anti-Virus Antibodies | Anti-Cytomegalovirus (CMV) gH glycoprotein [MSL-109] |
| Anti-Virus Antibodies | Anti-Cytomegalovirus glycoprotein B [ITC33] |
| Anti-Virus Antibodies | Anti-Dengue virus envelope protein [C9] |
| Anti-Virus Antibodies | Anti-DI/DII domain of Dengue E protein [DV18] |
| Anti-Virus Antibodies | Anti-DI/DII domain of Dengue E protein [DV78] |
| Anti-Virus Antibodies | Anti-DIII domain of Dengue E protein (DENV-1 and DENV-3) [DV63] |
| Anti-Virus Antibodies | Anti-DIII domain of Dengue E protein [DV10] |
| Anti-Virus Antibodies | Anti-Domain I of the DENV-4 envelope protein (E) [5H2] |
| Anti-Virus Antibodies | Anti-Domain II of the DENV-2 envelope protein (E) [1A5] |
| Anti-Virus Antibodies | Anti-dsRNA [1D3] |
| Anti-Virus Antibodies | Anti-dsRNA [9D5] |
| Anti-Virus Antibodies | Anti-dsRNA [J2] |
| Anti-Virus Antibodies | Anti-dsRNA/ssRNA [P6] |
| Anti-Virus Antibodies | Anti-E protein [13D6] |
| Anti-Virus Antibodies | Anti-E protein [14D5] |
| Anti-Virus Antibodies | Anti-E protein [Mab 4.2] |
| Anti-Virus Antibodies | Anti-E protein [T025] |
| Anti-Virus Antibodies | Anti-E-protein DIII (ABDE) [ZV-2] |
| Anti-Virus Antibodies | Anti-E-protein DIII (C-C') [ZV-48] |
| Anti-Virus Antibodies | Anti-E-protein DIII (C-C') [ZV-64] |
| Anti-Virus Antibodies | Anti-E-protein DIII (LR) [ZV-67] |
| Anti-Virus Antibodies | Anti-E1 protein [DC1.56] |
| Anti-Virus Antibodies | Anti-E1 protein [DC1.7] |
| Anti-Virus Antibodies | Anti-E2 [10B5 (RS10B5huFc)] |
| Anti-Virus Antibodies | Anti-E2 A domain [F5] |
| Anti-Virus Antibodies | Anti-E2 B domain [3b4c-4] |
| Anti-Virus Antibodies | Anti-E2 protein [Chk265] |
| Anti-Virus Antibodies | Anti-E2a protein [5B4D-6] |
| Anti-Virus Antibodies | Anti-E3E2 [WC10] |
| Anti-Virus Antibodies | Anti-Ebola GP [13F6-1-2] |
| Anti-Virus Antibodies | Anti-Ebola GP [h-13F6] |
| Anti-Virus Antibodies | Anti-Ebola Nucleoprotein [KZ51] |
| Anti-Virus Antibodies | Anti-Ebola Nucleoprotein [MJ6] |
| Anti-Virus Antibodies | Anti-Ebola Nucleoprotein [ZE] |
| Anti-Virus Antibodies | Anti-Ebola surface glycoprotein [KZ52] |
| Anti-Virus Antibodies | Anti-Ebola virus VP35 protein; [6c5] |
| Anti-Virus Antibodies | Anti-EBV Virus early antigen [1108.1] |
| Anti-Virus Antibodies | Anti-Entry-fusion complex associated protein OPG095 [M12B9] |
| Anti-Virus Antibodies | Anti-env, Envelope glycoprotein gp160 [Fab 58.2] |
| Anti-Virus Antibodies | Anti-env, Envelope glycoprotein gp160 [ITS090.03] |
| Anti-Virus Antibodies | Anti-Envelop glycoprotein B [93k] |
| Anti-Virus Antibodies | Anti-Envelope glycoprotein B [KE5] |
| Anti-Virus Antibodies | Anti-Envelope glycoprotein E2 [F5] |
| Anti-Virus Antibodies | Anti-Envelope glycoprotein Gc [A5] |
| Anti-Virus Antibodies | Anti-Envelope glycoprotein gp160 [0.5beta] |
| Anti-Virus Antibodies | Anti-Envelope glycoprotein H and L [94] |
| Anti-Virus Antibodies | Anti-Envelope glycoprotein H and L [rec-RC-IgG] |
| Anti-Virus Antibodies | Anti-Envelope glycoprotein H; Envelope glycoprotein L [Fab-RC] |
| Anti-Virus Antibodies | Anti-Envelope protein [5A] |
| Anti-Virus Antibodies | Anti-envelope protein [ZIKVEF2L01] |
| Anti-Virus Antibodies | Anti-envelope protein [ZIKVEF3S06] |
| Anti-Virus Antibodies | Anti-Envelope protein [ZKA64] |
| Anti-Virus Antibodies | Anti-Envelope protein [ZKA78] |
| Anti-Virus Antibodies | Anti-Envelope protein domain III [POWV-80] |
| Anti-Virus Antibodies | Anti-envelope protein domain IIII [Fab1] |
| Anti-Virus Antibodies | Anti-Envelope protein E [6B6C-1] |
| Anti-Virus Antibodies | Anti-Envelopment polyprotein [R12] |
| Anti-Virus Antibodies | Anti-Envelopment polyprotein [R13] |
| Anti-Virus Antibodies | Anti-Envelopment polyprotein [R15] |
| Anti-Virus Antibodies | Anti-Envelopment polyprotein [R17] |
| Anti-Virus Antibodies | Anti-Envelopment polyprotein [RV-Gn3] |
| Anti-Virus Antibodies | Anti-F glycoprotein [12B2] |
| Anti-Virus Antibodies | Anti-F protein [ACN044] |
| Anti-Virus Antibodies | Anti-F protein [DS7] |
| Anti-Virus Antibodies | Anti-F protein [mAb 234] |
| Anti-Virus Antibodies | Anti-F protein [mAb 338] |
| Anti-Virus Antibodies | Anti-Feline Calicivirus [1D7] |
| Anti-Virus Antibodies | Anti-FHV-1 [JH2] |
| Anti-Virus Antibodies | Anti-Flavivirus group antigen [2A10G6] |
| Anti-Virus Antibodies | Anti-Flavivirus group antigen [D1-4G2-4-15 (4G2)] |
| Anti-Virus Antibodies | Anti-Fusion glycoprotein F0 [01.4B] |
| Anti-Virus Antibodies | Anti-Fusion glycoprotein F0 [17-HD9] |
| Anti-Virus Antibodies | Anti-Fusion glycoprotein F0 [32.4K] |
| Anti-Virus Antibodies | Anti-Fusion glycoprotein F0 [anti-NiV-Fab66] |
| Anti-Virus Antibodies | Anti-Fusion glycoprotein F0 [B13] |
| Anti-Virus Antibodies | Anti-G-protein coupled receptor homolog US28 [Nb7] |
| Anti-Virus Antibodies | Anti-Gc [R5] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [14B10] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [18A7] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [1D5] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [1H10] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [38-1-10A] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [38-3-11A] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [3E31] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [AM28] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [anti-CVA16-14B10] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [anti-CVA16-NA9D7] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [AT12-015] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [C3] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [C5] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [DV62.5] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [E104] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [E106] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [HC33.4] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [HC33.8] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [MA28-7] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [NA9D7] |
| Anti-Virus Antibodies | Anti-Genome polyprotein [SD6] |
| Anti-Virus Antibodies | Anti-Ghana Virus F [7C11-LY] |
| Anti-Virus Antibodies | Anti-Ghana Virus G [10C4-LY] |
| Anti-Virus Antibodies | Anti-Ghana Virus G [10D5-LY] |
| Anti-Virus Antibodies | Anti-Glycoprotein [523-11] |
| Anti-Virus Antibodies | Anti-Glycoprotein [MR78] |
| Anti-Virus Antibodies | Anti-Glycoprotein B of HSV [Fd79] |
| Anti-Virus Antibodies | Anti-Glycoprotein Complex [37.7H] |
| Anti-Virus Antibodies | Anti-Glycoprotein D of HSV [Fd138-80] |
| Anti-Virus Antibodies | Anti-glycoprotein E [19/1786] |
| Anti-Virus Antibodies | Anti-Glycoprotein E1 [IGH526 (4805, 48G5C4)] |
| Anti-Virus Antibodies | Anti-Glycoprotein E2 [19B3] |
| Anti-Virus Antibodies | Anti-Glycoprotein E2 [212.1.1] |
| Anti-Virus Antibodies | Anti-Glycoprotein E2 [AP33] |
| Anti-Virus Antibodies | Anti-Glycoprotein E2 [HC-11] |
| Anti-Virus Antibodies | Anti-Glycoprotein E2 [HC-1AM] |
| Anti-Virus Antibodies | Anti-Glycoprotein E2 [HC33.1] |
| Anti-Virus Antibodies | Anti-Glycoprotein E2 [HC84.26.5D (HC26AM)] |
| Anti-Virus Antibodies | Anti-Glycoprotein G [NAbC] |
| Anti-Virus Antibodies | Anti-Glycoprotein H [A13-d6.3] |
| Anti-Virus Antibodies | Anti-Glycoprotein H [MAb 5] |
| Anti-Virus Antibodies | Anti-Gn [Mab-1 (23A8-1)] |
| Anti-Virus Antibodies | Anti-Gn [Mab-2 (23B5-1)] |
| Anti-Virus Antibodies | Anti-Gn [Mab-3 (32A8-1)] |
| Anti-Virus Antibodies | Anti-Gn [R16] |
| Anti-Virus Antibodies | Anti-Gn [RV-Gn1] |
| Anti-Virus Antibodies | Anti-gp120 [Clone 101] |
| Anti-Virus Antibodies | Anti-gp120 [Clone 102] |
| Anti-Virus Antibodies | Anti-gp120 [Clone 201] |
| Anti-Virus Antibodies | Anti-gp120 [Y498] |
| Anti-Virus Antibodies | Anti-gp120 protein (CD4-binding domain) [448-D] |
| Anti-Virus Antibodies | Anti-gp120 protein (CD4-binding domain) [559/64-D] |
| Anti-Virus Antibodies | Anti-gp140 [VHH28] |
| Anti-Virus Antibodies | Anti-gp140 [VHH5] |
| Anti-Virus Antibodies | Anti-gp41 [A2] |
| Anti-Virus Antibodies | Anti-gp41 [A7] |
| Anti-Virus Antibodies | Anti-H protein [NB2] |
| Anti-Virus Antibodies | Anti-HA [8H5] |
| Anti-Virus Antibodies | Anti-HA [AV.C4] |
| Anti-Virus Antibodies | Anti-HA [AV.D1] |
| Anti-Virus Antibodies | Anti-HA [AV.G4] |
| Anti-Virus Antibodies | Anti-HA [C179] |
| Anti-Virus Antibodies | Anti-HA [CR6261] |
| Anti-Virus Antibodies | Anti-HA [CR8020] |
| Anti-Virus Antibodies | Anti-HA [F113-135] |
| Anti-Virus Antibodies | Anti-HA [FB75] |
| Anti-Virus Antibodies | Anti-HA [FC41] |
| Anti-Virus Antibodies | Anti-HA [FE17] |
| Anti-Virus Antibodies | Anti-HA [Mab 3.1] |
| Anti-Virus Antibodies | Anti-HA2 [3JA18] |
| Anti-Virus Antibodies | Anti-Hantaan virus GP [3G1] |
| Anti-Virus Antibodies | Anti-HAV IRES domain V [HAVx] |
| Anti-Virus Antibodies | Anti-HBeAg [E6] |
| Anti-Virus Antibodies | Anti-HBsAg [5C3] |
| Anti-Virus Antibodies | Anti-HBsAg [F124] |
| Anti-Virus Antibodies | Anti-HBV [HBV#8] |
| Anti-Virus Antibodies | Anti-HBV pre-S1 protein [MA18/7] |
| Anti-Virus Antibodies | Anti-HBV pre-S2 protein [1F6] |
| Anti-Virus Antibodies | Anti-HCMV [8F9] |
| Anti-Virus Antibodies | Anti-HCMV gB [5A6] |
| Anti-Virus Antibodies | Anti-HCMV gH [HCMV16] |
| Anti-Virus Antibodies | Anti-HCV E1 [5D2] |
| Anti-Virus Antibodies | Anti-HCV E1E2 complex [AR4A (N4)] |
| Anti-Virus Antibodies | Anti-HCV IRES junction IIIabc [HCV2] |
| Anti-Virus Antibodies | Anti-HCV NS3 Protein [Hfab-aNS3] |
| Anti-Virus Antibodies | Anti-Hemagglutinin [17/9] |
| Anti-Virus Antibodies | Anti-hemagglutinin H1 [3978] |
| Anti-Virus Antibodies | Anti-hemagglutinin H1 [5589] |
| Anti-Virus Antibodies | Anti-hemagglutinin H1 [7665] |
| Anti-Virus Antibodies | Anti-hemagglutinin H3 [1664] |
| Anti-Virus Antibodies | Anti-Hendra and Nipah virus F [1F5] |
| Anti-Virus Antibodies | Anti-Hendra and Nipah virus G [48D3] |
| Anti-Virus Antibodies | Anti-Hendra and Nipah virus G [5B1] |
| Anti-Virus Antibodies | Anti-Hendra and Nipah virus G [7B7] |
| Anti-Virus Antibodies | Anti-Hepatitis A virus capsid [R10] |
| Anti-Virus Antibodies | Anti-hepatitis B virus core antigen [AbAbHBcAg01] |
| Anti-Virus Antibodies | Anti-Hepatitis delta antigen [FD3A7] |
| Anti-Virus Antibodies | Anti-Hepatitis delta antigen [FD5C4] |
| Anti-Virus Antibodies | Anti-Herpes simplex IgD [124/468] |
| Anti-Virus Antibodies | Anti-Herpes simplex virus [H37] |
| Anti-Virus Antibodies | Anti-Herpes simplex virus [H85] |
| Anti-Virus Antibodies | Anti-Hexon [9C12] |
| Anti-Virus Antibodies | Anti-His tag [4C9] |
| Anti-Virus Antibodies | Anti-His tag [H343] |
| Anti-Virus Antibodies | Anti-His tag [H7219] |
| Anti-Virus Antibodies | Anti-HIV capsid protein p24 [13B5] |
| Anti-Virus Antibodies | Anti-HIV capsid protein p24 [CB4-1] |
| Anti-Virus Antibodies | Anti-HIV GP120 [JM4] |
| Anti-Virus Antibodies | Anti-HIV GP41 [2E7 (L92E7)] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [0.5B] |
| Anti-Virus Antibodies | Anti-HIV-1 gp120 [694-D] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [b12 (MT12)] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [HGD65] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [HGN194] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [HGZ1] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [HJ16] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [HR10] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [HR12] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [PGT124] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [VRC03] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [X5] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [YZ18] |
| Anti-Virus Antibodies | Anti-HIV-1 GP120 [YZ23] |
| Anti-Virus Antibodies | Anti-HIV-1 GP41 [HGF24] |
| Anti-Virus Antibodies | Anti-HIV-1 GP41 [HK20] |
| Anti-Virus Antibodies | Anti-HLA-A02:01 EBV-LMP2A complex [Mab243] |
| Anti-Virus Antibodies | Anti-HLA/EBNA1 [anti-HLA-A0201/EBNA1 antibody] |
| Anti-Virus Antibodies | Anti-HN Protein [1A6] |
| Anti-Virus Antibodies | Anti-HPV16 E7 protein [69E2] |
| Anti-Virus Antibodies | Anti-HPV16 E7 protein [79A11] |
| Anti-Virus Antibodies | Anti-HPV16E6 & HPV18E6 [C1P5] |
| Anti-Virus Antibodies | Anti-HSV-1 VP5 [6F10-D2-G2] |
| Anti-Virus Antibodies | Anti-Human Rhinovirus 14 [Fab17-IA] |
| Anti-Virus Antibodies | Anti-iC3b [5D2] |
| Anti-Virus Antibodies | Anti-IFNa 2b [scFv 17] |
| Anti-Virus Antibodies | Anti-IFNA 8 [α8#139] |
| Anti-Virus Antibodies | Anti-IFNA 8 [α8Y36-2] |
| Anti-Virus Antibodies | Anti-IFNAR-1 [64G12] |
| Anti-Virus Antibodies | Anti-infectious bursal disease virus [CRAb154] |
| Anti-Virus Antibodies | Anti-infectious bursal disease virus VP2 [CRAb 88] |
| Anti-Virus Antibodies | Anti-influenza [2-8C] |
| Anti-Virus Antibodies | Anti-influenza [2-12C] |
| Anti-Virus Antibodies | Anti-influenza [3-10B] |
| Anti-Virus Antibodies | Anti-influenza [T1-3B] |
| Anti-Virus Antibodies | Anti-Influenza A HA [FLD127] |
| Anti-Virus Antibodies | Anti-Influenza A HA [FLD20] |
| Anti-Virus Antibodies | Anti-Influenza A HA [FLD21] |
| Anti-Virus Antibodies | Anti-Influenza A HA [FLD84] |
| Anti-Virus Antibodies | Anti-Influenza A HA [FLD93] |
| Anti-Virus Antibodies | Anti-Influenza A HA [HA] |
| Anti-Virus Antibodies | Anti-Influenza A nucleoprotein [aNP-VHH1] |
| Anti-Virus Antibodies | Anti-Influenza A virus NS1 [NS1-23-1] |
| Anti-Virus Antibodies | Anti-Integrase [scFvs 104] |
| Anti-Virus Antibodies | Anti-Integrase [scFvs 135] |
| Anti-Virus Antibodies | Anti-JEV virions (E/PrM) [TJE12B02] |
| Anti-Virus Antibodies | Anti-Junin virus GP1 [CR1-10] |
| Anti-Virus Antibodies | Anti-Junin virus GP1 [GD01] |
| Anti-Virus Antibodies | Anti-Junin virus GP1 [GD01] |
| Anti-Virus Antibodies | Anti-Junin virus GP1 [JUN1] |
| Anti-Virus Antibodies | Anti-Junin virus GP1 [OD01] |
| Anti-Virus Antibodies | Anti-Junin virus Nucleoprotein [J1.2] |
| Anti-Virus Antibodies | Anti-La Crosse virus, G1 envelope glycoprotein [807.15] |
| Anti-Virus Antibodies | Anti-La Crosse virus, G1 envelope glycoprotein [807.31] |
| Anti-Virus Antibodies | Anti-LAM [CS-35] |
| Anti-Virus Antibodies | Anti-Large envelope protein [PC282] |
| Anti-Virus Antibodies | Anti-Large envelope protein [PC283] |
| Anti-Virus Antibodies | Anti-Large envelope protein [PC287] |
| Anti-Virus Antibodies | Anti-LDL receptor [12G4] |
| Anti-Virus Antibodies | Anti-LMP1 [H11F6] |
| Anti-Virus Antibodies | Anti-LMP1 [S12] |
| Anti-Virus Antibodies | Anti-LMP2A [14B7] |
| Anti-Virus Antibodies | Anti-M13 bacteriophage [E1] |
| Anti-Virus Antibodies | Anti-Machupo virus GP1 [MAC1] |
| Anti-Virus Antibodies | Anti-Major capsid protein L1 [28F10] |
| Anti-Virus Antibodies | Anti-Major capsid protein L1 [A12A3] |
| Anti-Virus Antibodies | Anti-Major capsid protein L1 [H16.14J] |
| Anti-Virus Antibodies | Anti-Major capsid protein L1 [H16.1A] |
| Anti-Virus Antibodies | Anti-Major capsid protein L1 [H16.U4] |
| Anti-Virus Antibodies | Anti-Major capsid protein L1 [H263.A2] |
| Anti-Virus Antibodies | Anti-Marburg virus nucleoprotein [sdAb 4] |
| Anti-Virus Antibodies | Anti-Matrix Protein [E10] |
| Anti-Virus Antibodies | Anti-MERS CoV [45C2] |
| Anti-Virus Antibodies | Anti-MERS-CoV Spike protein [1F8] |
| Anti-Virus Antibodies | Anti-MERS-CoV Spike protein [2E6] |
| Anti-Virus Antibodies | Anti-MERS-CoV Spike protein [3A1] |
| Anti-Virus Antibodies | Anti-MERS-CoV Spike protein [3B12] |
| Anti-Virus Antibodies | Anti-MERS-CoV Spike Protein [4c2] |
| Anti-Virus Antibodies | Anti-MERS-CoV Spike protein [M14D3] |
| Anti-Virus Antibodies | Anti-Mojiang Virus F [3C4-LY] |
| Anti-Virus Antibodies | Anti-Mojiang Virus F [4G5-LY] |
| Anti-Virus Antibodies | Anti-Mojiang Virus G [10G2-LY] |
| Anti-Virus Antibodies | Anti-Mojiang Virus G [6E5-LY] |
| Anti-Virus Antibodies | Anti-Monkeypox and Vaccinia A13 protein [11F7] |
| Anti-Virus Antibodies | Anti-Monkeypox Virus [VACV-5C7] |
| Anti-Virus Antibodies | Anti-MPXV A29L protein [4E9] |
| Anti-Virus Antibodies | Anti-MPXV A29L protein [7B10] |
| Anti-Virus Antibodies | Anti-MPXV A29L protein [AbAb02-MPXV] |
| Anti-Virus Antibodies | Anti-MPXV A29L protein [AbAb03-MPXV] |
| Anti-Virus Antibodies | Anti-MPXV A29L protein [B8 (R3P2-B8)] |
| Anti-Virus Antibodies | Anti-MPXV A29L protein [H9 (R3P2-H9)] |
| Anti-Virus Antibodies | Anti-MPXV A35 protein [7G5] |
| Anti-Virus Antibodies | Anti-MPXV A35 protein [MPXV-mAb 975] |
| Anti-Virus Antibodies | Anti-MPXV A35 protein [MV129] |
| Anti-Virus Antibodies | Anti-MPXV A35R protein [AbAb01-MPXV] |
| Anti-Virus Antibodies | Anti-MPXV B6R protein [B026] |
| Anti-Virus Antibodies | Anti-MPXV M1R protein [A128] |
| Anti-Virus Antibodies | Anti-MPXV M1R protein [mab26] |
| Anti-Virus Antibodies | Anti-Murine leukemia virus p30 gag capsid polypeptide [R187] |
| Anti-Virus Antibodies | Anti-N9 Neuraminidase [NC41 ] |
| Anti-Virus Antibodies | Anti-NA, Neuraminidase [NA-22] |
| Anti-Virus Antibodies | Anti-NA, Neuraminidase [NA-45] |
| Anti-Virus Antibodies | Anti-NA, Neuraminidase [NA-63] |
| Anti-Virus Antibodies | Anti-NA, Neuraminidase [NA-63] |
| Anti-Virus Antibodies | Anti-NA, Neuraminidase [NA-73] |
| Anti-Virus Antibodies | Anti-NA, Neuraminidase [NA-80] |
| Anti-Virus Antibodies | Anti-NA, Neuraminidase [NA-80] |
| Anti-Virus Antibodies | Anti-Neuraminidase [Mem5] |
| Anti-Virus Antibodies | Anti-Neuraminidase [NC10] |
| Anti-Virus Antibodies | Anti-Neutralizing Epitope [ZKA185] |
| Anti-Virus Antibodies | Anti-Newcastle disease virus [Antibody A] |
| Anti-Virus Antibodies | Anti-Newcastle disease virus [ZL1] |
| Anti-Virus Antibodies | Anti-Nipah and Hendra G [nAH1.3] |
| Anti-Virus Antibodies | Anti-Nipah virus F F1 [5G7] |
| Anti-Virus Antibodies | Anti-Nipah virus F F2 [11F10] |
| Anti-Virus Antibodies | Anti-Nipah virus F F2 [6D3] |
| Anti-Virus Antibodies | Anti-Nipah virus F Site I [16C2] |
| Anti-Virus Antibodies | Anti-Nipah virus F Site II [4C9] |
| Anti-Virus Antibodies | Anti-Nipah virus F Site IV [1E 11] |
| Anti-Virus Antibodies | Anti-Nipah virus F1 [13G5] |
| Anti-Virus Antibodies | Anti-Norovirus capsid protein VP1 [A1227] |
| Anti-Virus Antibodies | Anti-Norovirus GII.4 [NVB43.9] |
| Anti-Virus Antibodies | Anti-Norovirus GII.4 P domain [A1431] |
| Anti-Virus Antibodies | Anti-Norovirus GII.4 VP1 [8E1] |
| Anti-Virus Antibodies | Anti-Norovirus P domain [Nano-27] |
| Anti-Virus Antibodies | Anti-Norovirus P domain [Nano-4] |
| Anti-Virus Antibodies | Anti-Notch 1 [WC613] |
| Anti-Virus Antibodies | Anti-Notch 1 [WC75] |
| Anti-Virus Antibodies | Anti-NP [JS08] |
| Anti-Virus Antibodies | Anti-NP [JS08] |
| Anti-Virus Antibodies | Anti-NP [JS16] |
| Anti-Virus Antibodies | Anti-NP [JS16] |
| Anti-Virus Antibodies | Anti-NS1 [22NS1] |
| Anti-Virus Antibodies | Anti-NS1 [32] |
| Anti-Virus Antibodies | Anti-NS1 [clone n.10] |
| Anti-Virus Antibodies | Anti-NS1 [clone n.11] |
| Anti-Virus Antibodies | Anti-NS1 [Clone n.3] |
| Anti-Virus Antibodies | Anti-NS1 [D6] |
| Anti-Virus Antibodies | Anti-NS1 [ZKA35] |
| Anti-Virus Antibodies | Anti-NS5B protein of BVD virus [Nb1] |
| Anti-Virus Antibodies | Anti-nucleocapsid (N) protein [Nb1] |
| Anti-Virus Antibodies | Anti-Nucleocapsid protein [KC329705] |
| Anti-Virus Antibodies | Anti-Nucleoprotein [1004] |
| Anti-Virus Antibodies | Anti-Nucleoprotein [1307] |
| Anti-Virus Antibodies | Anti-nucleoprotein [1C7] |
| Anti-Virus Antibodies | Anti-Nucleoprotein [1N8] |
| Anti-Virus Antibodies | Anti-nucleoprotein [5H7] |
| Anti-Virus Antibodies | Anti-Nucleoprotein [Nb1] |
| Anti-Virus Antibodies | Anti-Nucleoprotein [sdAb SB] |
| Anti-Virus Antibodies | Anti-Orthopoxviruses (incl Ectromelia & Monkeypox) [VACV-5B1] |
| Anti-Virus Antibodies | Anti-Outer capsid protein VP4 [#9] |
| Anti-Virus Antibodies | Anti-P protein [ZL.6 (ZL2)] |
| Anti-Virus Antibodies | Anti-P32 [AbAb-LSD-1] |
| Anti-Virus Antibodies | Anti-p35 protein of Orthopoxvirus [1A] |
| Anti-Virus Antibodies | Anti-Parvovirus [MAbE] |
| Anti-Virus Antibodies | Anti-peptides (neutralizing epitope) [Clone 36] |
| Anti-Virus Antibodies | Anti-PERV [7C4] |
| Anti-Virus Antibodies | Anti-PERV [A5] |
| Anti-Virus Antibodies | Anti-PERV p27 [D2] |
| Anti-Virus Antibodies | Anti-Polymerase cofactor VP35 [sFab H3] |
| Anti-Virus Antibodies | Anti-Potato virus V coat protein [scFv40 (SCR40)] |
| Anti-Virus Antibodies | Anti-Potato virus Y coat protein [42C07] |
| Anti-Virus Antibodies | Anti-Potato virus Y NIa [22-19] |
| Anti-Virus Antibodies | Anti-Potato virus Y NIa [SA2] |
| Anti-Virus Antibodies | Anti-Poxvirus L1 Protein [Fab 7d11] |
| Anti-Virus Antibodies | Anti-pre- and post-fusion conformation of HRSV F protein [RSB15] |
| Anti-Virus Antibodies | Anti-pre- and post-fusion conformation of HRSV F protein [RSB16] |
| Anti-Virus Antibodies | Anti-pre-fusion conformation of HRSV F protein [RSB20] |
| Anti-Virus Antibodies | Anti-pre-fusion conformation of HRSV F protein [RSB43] |
| Anti-Virus Antibodies | Anti-pre-fusion viral F protein [MPE8] |
| Anti-Virus Antibodies | Anti-Protein OPG154 [1G6] |
| Anti-Virus Antibodies | Anti-Protein OPG161 [A20G2] |
| Anti-Virus Antibodies | Anti-Protein OPG161 [A27D7] |
| Anti-Virus Antibodies | Anti-PRSV coat protein [9G2D3] |
| Anti-Virus Antibodies | Anti-Rabies Virus 67kDa protein [EP5G3] |
| Anti-Virus Antibodies | Anti-Rabies Virus 67kDa protein [Fab094] |
| Anti-Virus Antibodies | Anti-Rabies Virus 67kDa protein [GD2D12] |
| Anti-Virus Antibodies | Anti-Rabies Virus Glycoprotein [A11] |
| Anti-Virus Antibodies | Anti-Rabies Virus Glycoprotein [C12] |
| Anti-Virus Antibodies | Anti-Rabies Virus Glycoprotein [R16E5] |
| Anti-Virus Antibodies | Anti-RNA-directed RNA polymerase L [SUDV MTase VHH] |
| Anti-Virus Antibodies | Anti-Rotavirus [2B10 (ARP1; VHH1)] |
| Anti-Virus Antibodies | Anti-Rotavirus A capsid glycoprotein VP7 [4F8] |
| Anti-Virus Antibodies | Anti-RRV E2 [D7] |
| Anti-Virus Antibodies | Anti-RSV [RSHZ19 (Felvizumab)] |
| Anti-Virus Antibodies | Anti-RSV G protein [131-2G] |
| Anti-Virus Antibodies | Anti-RSV G protein [CB002.5] |
| Anti-Virus Antibodies | Anti-S protein (RBD) [1E2] |
| Anti-Virus Antibodies | Anti-S protein (RBD) [5F8] |
| Anti-Virus Antibodies | Anti-S protein (RBD) [aRBD-2] |
| Anti-Virus Antibodies | Anti-S protein (RBD) [aRBD-5] |
| Anti-Virus Antibodies | Anti-S protein (RBD) [aRBD-7] |
| Anti-Virus Antibodies | Anti-S protein (RBD) [STE90-C11] |
| Anti-Virus Antibodies | Anti-S protein [6E6] |
| Anti-Virus Antibodies | Anti-S protein [Fab58] |
| Anti-Virus Antibodies | Anti-S protein [P17] |
| Anti-Virus Antibodies | Anti-S2 domain [S2A3] |
| Anti-Virus Antibodies | Anti-Saint Louis encephalitis virus envelope glycoprotein [6B6C-1] |
| Anti-Virus Antibodies | Anti-SAR-55 ORF2 [HEV#31] |
| Anti-Virus Antibodies | Anti-SARS-CoV Nucleoprotein [N18] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [11A] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [1B5] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [256] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [4D4] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [4G2] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [4S1] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [5D3] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [5E4] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [6B1] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [A11] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [F26G10] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [F26G19] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [F26G9] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [Lsc18] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S109] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S110] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S124] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S215] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S217] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S222] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S223] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S225] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S226] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S227] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S228] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S230] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [S231] |
| Anti-Virus Antibodies | Anti-SARS-CoV S glycoprotein [Ssc35] |
| Anti-Virus Antibodies | Anti-SARS-CoV-2 and SARS-CoV nucleocapsid [mBG17] |
| Anti-Virus Antibodies | Anti-SARS-CoV-2 nucleocapsid [mBG86] |
| Anti-Virus Antibodies | Anti-SARS-CoV-2 Spike protein (RBD monomer) [2B-E7-C9] |
| Anti-Virus Antibodies | Anti-SARS-CoV-2 Spike protein (RBD monomer) [2B-G10-A1] |
| Anti-Virus Antibodies | Anti-SEB [6D3] |
| Anti-Virus Antibodies | Anti-Severe Fever and Thrombocytopenic Syndrome Virus [2D10] |
| Anti-Virus Antibodies | Anti-Severe Fever and Thrombocytopenic Syndrome Virus [3A10 ] |
| Anti-Virus Antibodies | Anti-Severe Fever and Thrombocytopenic Syndrome Virus [MAb4-5] |
| Anti-Virus Antibodies | Anti-SFTSV [40C10] |
| Anti-Virus Antibodies | Anti-SFTSV [B1G11 ] |
| Anti-Virus Antibodies | Anti-SFTSV [S2A5] |
| Anti-Virus Antibodies | Anti-SFTSV glycoprotein C [1C5-F5] |
| Anti-Virus Antibodies | Anti-SFTSV glycoprotein C [1H6-B10] |
| Anti-Virus Antibodies | Anti-SFTSV glycoprotein C [Gc-b3-1E2] |
| Anti-Virus Antibodies | Anti-SFTSV glycoprotein C [SF83] |
| Anti-Virus Antibodies | Anti-SFTSV glycoprotein N [SF5] |
| Anti-Virus Antibodies | Anti-Spike protein [EY6A] |
| Anti-Virus Antibodies | Anti-Spike protein [MR17 ] |
| Anti-Virus Antibodies | Anti-Spike protein [MR3] |
| Anti-Virus Antibodies | Anti-Spike protein [Sb23] |
| Anti-Virus Antibodies | Anti-Spike protein [SR4] |
| Anti-Virus Antibodies | Anti-Spike protein [Ty1] |
| Anti-Virus Antibodies | Anti-Spike Protein (RBD) [CV30] |
| Anti-Virus Antibodies | Anti-Spike protein (RBD) [Sb#14] |
| Anti-Virus Antibodies | Anti-Spike protein (RBD) [Sb#15] |
| Anti-Virus Antibodies | Anti-Spike protein (RBD) [Sb#16] |
| Anti-Virus Antibodies | Anti-Spike protein (RBD) [Sb#42] |
| Anti-Virus Antibodies | Anti-Spike protein (RBD) [Sb#45] |
| Anti-Virus Antibodies | Anti-Spike protein (RBD) [Sb#68] |
| Anti-Virus Antibodies | Anti-Spike protein [18F4] |
| Anti-Virus Antibodies | Anti-Spike protein [3B-D7-C2] |
| Anti-Virus Antibodies | Anti-Spike protein [3B-G3-C6] |
| Anti-Virus Antibodies | Anti-Spike protein [4A8] |
| Anti-Virus Antibodies | Anti-Spike Protein [CV1] |
| Anti-Virus Antibodies | Anti-Spike protein [D70678-5521-S2] |
| Anti-Virus Antibodies | Anti-spike protein [TZZ14] |
| Anti-Virus Antibodies | Anti-spike protein [TZZ19] |
| Anti-Virus Antibodies | Anti-SPLCV Coat protein [scFvF7] |
| Anti-Virus Antibodies | Anti-Structural polyprotein [CHK152] |
| Anti-Virus Antibodies | Anti-Structural polyprotein [CHK152] |
| Anti-Virus Antibodies | Anti-Tetanus toxoid [F13] |
| Anti-Virus Antibodies | Anti-TGEV Coronavirus Spike glycoprotein [1AF10] |
| Anti-Virus Antibodies | Anti-Tobacco mosaic virus [Mab24] |
| Anti-Virus Antibodies | Anti-Tomato Leaf Curl Sudan Virus [Nb-To2] |
| Anti-Virus Antibodies | Anti-Tumor necrosis factor receptor superfamily member 4 [008] |
| Anti-Virus Antibodies | Anti-Tumor necrosis factor receptor superfamily member 4 [023] |
| Anti-Virus Antibodies | Anti-Tumor necrosis factor receptor superfamily member 4 [20E5] |
| Anti-Virus Antibodies | Anti-UL42 [4E2] |
| Anti-Virus Antibodies | Anti-UL42 [5F8] |
| Anti-Virus Antibodies | Anti-Usutu virus envelop protein E [A8] |
| Anti-Virus Antibodies | Anti-Usutu virus envelop protein E [A9] |
| Anti-Virus Antibodies | Anti-V5 epitope tag [SV5-P-K] |
| Anti-Virus Antibodies | Anti-Vaccinia A33 glycoprotein [A2C7] |
| Anti-Virus Antibodies | Anti-Vaccinia virus [G] |
| Anti-Virus Antibodies | Anti-Vesicular stomatitis virus nucleoprotein N [VHH-1004] |
| Anti-Virus Antibodies | Anti-viral matrix protein VP40, nucleoprotein [DSTL094] |
| Anti-Virus Antibodies | Anti-VLP of CPV-VP2 [scFv 96] |
| Anti-Virus Antibodies | Anti-VP1 protein [4C4] |
| Anti-Virus Antibodies | Anti-VP1 protein [860-55D] |
| Anti-Virus Antibodies | Anti-VP1 protein [EBB-C1975-B5] |
| Anti-Virus Antibodies | Anti-VP1 protein [F24G2] |
| Anti-Virus Antibodies | Anti-VP1 protein [NEG447A] |
| Anti-Virus Antibodies | Anti-VP1 protein [sdAb-C6] |
| Anti-Virus Antibodies | Anti-VP2 [8F5] |
| Anti-Virus Antibodies | Anti-VP28 [Mab 216] |
| Anti-Virus Antibodies | Anti-VP28 [P75E8] |
| Anti-Virus Antibodies | Anti-VP35 [H3] |
| Anti-Virus Antibodies | Anti-VSV-M [23H12] |
| Anti-Virus Antibodies | Anti-VSV-N [10G4] |
| Anti-Virus Antibodies | Anti-WNV Envelope protein [9E2] |
| Anti-Virus Antibodies | Anti-WNV Envelope protein DI-DII [E53] |
| Anti-Virus Antibodies | Anti-Yellow Fever Virus [2D12] |
| Anti-Virus Antibodies | Anti-ZIKV E domain II [SMZAb2] |
| Anti-Virus Antibodies | Anti-ZIKV E domain III [SMZAb1] |
| Anti-Virus Antibodies | Anti-ZIKV E domain III [SMZAb5] |
| Anti-Virus Antibodies | Anti-ZIKV E domain III [Z004] |
| Anti-Virus Antibodies | Anti-ZIKV soluble envelope protein [z23] |
| DNA/RNA Research Antibodies | Anti-(6-4) DNA photoproducts [64M-2] |
| DNA/RNA Research Antibodies | Anti-(6-4) DNA photoproducts [64M-5] |
| DNA/RNA Research Antibodies | Anti-5-Hydroxymethylcytosine [AB3/63.3] |
| DNA/RNA Research Antibodies | Anti-Cisplatin modified DNA [CP9/19] |
| DNA/RNA Research Antibodies | Anti-DNA-RNA hybrid [S9.6] |
| DNA/RNA Research Antibodies | Anti-DNA/RNA G-quadruplex [BG4] |
| DNA/RNA Research Antibodies | Anti-Hairpin DNA [DNA-1] |
| DNA/RNA Research Antibodies | Anti-i-motif DNA [iMab] |
| DNA/RNA Research Antibodies | Anti-N6-methyladenosine [17-3-4-1] |
| DNA/RNA Research Antibodies | Anti-Quadruplex DNA [1H6] |
| DNA/RNA Research Antibodies | Anti-Quadruplex DNA [4E11] |
| DNA/RNA Research Antibodies | Anti-Quadruplex DNA [5E11] |
| DNA/RNA Research Antibodies | Anti-Quadruplex DNA [8H2] |
| DNA/RNA Research Antibodies | Anti-single-stranded poly(rI) RNA [Jel 103] |
| DNA/RNA Research Antibodies | Anti-ss/dsDNA [A52] |
| DNA/RNA Research Antibodies | Anti-ssDNA/dsDNA [m3D8] |
| DNA/RNA Research Antibodies | Anti-Triplex DNA [Jel 466] |
| DNA/RNA Research Antibodies | Anti-Z-DNA/Z-RNA [Z22] |
| Recombinant Antibodies from Human Patients | Anti-desmoglein-3 [PVA218] |
| Recombinant Antibodies from Human Patients | Anti-desmoglein-3 [PVA232] |
| Recombinant Antibodies from Human Patients | Anti-desmoglein-3 [PVB124] |
| Recombinant Antibodies from Human Patients | Anti-desmoglein-3 [PVB16] |
| Recombinant Antibodies from Human Patients | Anti-desmoglein-3 [PVB28] |
| Recombinant Antibodies from Human Patients | Anti-desmoglein-3 and desmoglein-1 [PVA224] |
| Recombinant Antibodies from Human Patients | Anti-desmoglein-3 and desmoglein-1 [PVA3] |
| Recombinant Antibodies from Human Patients | Anti-DI/DII domain of Dengue E protein [DV18] |
| Recombinant Antibodies from Human Patients | Anti-DI/DII domain of Dengue E protein [DV78] |
| Recombinant Antibodies from Human Patients | Anti-DIII domain of Dengue E protein (DENV-1 and DENV-3) [DV63] |
| Recombinant Antibodies from Human Patients | Anti-DIII domain of Dengue E protein [DV10] |
| Recombinant Antibodies from Human Patients | Anti-Ebola Nucleoprotein [KZ51] |
| Recombinant Antibodies from Human Patients | Anti-Ebola surface glycoprotein [KZ52] |
| Recombinant Antibodies from Human Patients | Anti-GM-CSF [GCA43] |
| Recombinant Antibodies from Human Patients | Anti-GM-CSF [GCC21] |
| Recombinant Antibodies from Human Patients | Anti-HA [FB75] |
| Recombinant Antibodies from Human Patients | Anti-HA [FC41] |
| Recombinant Antibodies from Human Patients | Anti-HA [FE17] |
| Recombinant Antibodies from Human Patients | Anti-HIV-1 GP120 [HGD65] |
| Recombinant Antibodies from Human Patients | Anti-HIV-1 GP120 [HGN194] |
| Recombinant Antibodies from Human Patients | Anti-HIV-1 GP120 [HGZ1] |
| Recombinant Antibodies from Human Patients | Anti-HIV-1 GP120 [HJ16] |
| Recombinant Antibodies from Human Patients | Anti-HIV-1 GP120 [HR10] |
| Recombinant Antibodies from Human Patients | Anti-HIV-1 GP120 [HR12] |
| Recombinant Antibodies from Human Patients | Anti-HIV-1 GP41 [HGF24] |
| Recombinant Antibodies from Human Patients | Anti-HIV-1 GP41 [HK20] |
| Recombinant Antibodies from Human Patients | Anti-Influenza A HA [FLD127] |
| Recombinant Antibodies from Human Patients | Anti-Influenza A HA [FLD20] |
| Recombinant Antibodies from Human Patients | Anti-Influenza A HA [FLD21] |
| Recombinant Antibodies from Human Patients | Anti-Influenza A HA [FLD84] |
| Recombinant Antibodies from Human Patients | Anti-Influenza A HA [FLD93] |
| Recombinant Antibodies from Human Patients | Anti-Influenza A HA [HA] |
| Recombinant Antibodies from Human Patients | Anti-Norovirus GII.4 [NVB43.9] |
| Recombinant Antibodies from Human Patients | Anti-pre- and post-fusion conformation of HRSV F protein [RSB15] |
| Recombinant Antibodies from Human Patients | Anti-pre- and post-fusion conformation of HRSV F protein [RSB16] |
| Recombinant Antibodies from Human Patients | Anti-pre-fusion conformation of HRSV F protein [RSB20] |
| Recombinant Antibodies from Human Patients | Anti-pre-fusion conformation of HRSV F protein [RSB43] |
| Recombinant Antibodies from Human Patients | Anti-Rh(D) [FOG-1] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S109] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S110] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S124] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S215] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S217] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S222] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S223] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S225] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S226] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S227] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S228] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S230] |
| Recombinant Antibodies from Human Patients | Anti-SARS-CoV S glycoprotein [S231] |
| Research-Grade Biosimilars | Anti-alpha 5 beta 1 Integrin [M200 (Volociximab)] |
| Research-Grade Biosimilars | Anti-Amyloid beta A4 protein [LY2062430 (Solanezumab, hu266)] |
| Research-Grade Biosimilars | Anti-C5 [Eculizumab] |
| Research-Grade Biosimilars | Anti-carcinoembryonic antigen (CEA) [Arcitumomab] |
| Research-Grade Biosimilars | Anti-CCL11 [CAT-213 (Bertilimumab; iCo-008)] |
| Research-Grade Biosimilars | Anti-CCR2 [MLN1202 (Plozalizumab, hu1D9)] |
| Research-Grade Biosimilars | Anti-CCR4 [KW-0761 (Mogamulizumab)] |
| Research-Grade Biosimilars | Anti-CD105 [TRC105 (Carotuximab)] |
| Research-Grade Biosimilars | Anti-CD11a [hu1124 (Efalizumab)] |
| Research-Grade Biosimilars | Anti-CD154 [IDEC-131 (Toralizumab)] |
| Research-Grade Biosimilars | Anti-CD20 [10F381 (rituximab)] |
| Research-Grade Biosimilars | Anti-CD22 [hL22 (Epratuzumab)] |
| Research-Grade Biosimilars | Anti-CD25 [YTH 906.9HL (Campath-6)] |
| Research-Grade Biosimilars | Anti-CD257 (BAFF) [Tabalumab] |
| Research-Grade Biosimilars | Anti-CD257 [I116A01 (Belimumab)] |
| Research-Grade Biosimilars | Anti-CD3 epsilon [OKT-3 (muromonab)] |
| Research-Grade Biosimilars | Anti-CD30 [AC10 (Brentuximab)] |
| Research-Grade Biosimilars | Anti-CD33 [hP67.6 (Gemtuzumab)] |
| Research-Grade Biosimilars | Anti-CD33 [SGN-33 (Lintuzumab)] |
| Research-Grade Biosimilars | Anti-CD4 [CE9.1 (Clenoliximab)] |
| Research-Grade Biosimilars | Anti-CD4 [MT310] |
| Research-Grade Biosimilars | Anti-CD4 [YNB46.1.8 (Campath-9H)] |
| Research-Grade Biosimilars | Anti-CD40L [hu5c8 (Ruplizumab)] |
| Research-Grade Biosimilars | Anti-CD41 [7E3 (Abciximab)] |
| Research-Grade Biosimilars | Anti-CD49B [GBR500 (Vatelizumab, TMC-2206)] |
| Research-Grade Biosimilars | Anti-CD52 [Alemtuzumab (Campath-1H)] |
| Research-Grade Biosimilars | Anti-CD52 [YTH 34.5-G2b (Campath-1G)] |
| Research-Grade Biosimilars | Anti-CD80 [IDEC-114 (Galiximab)] |
| Research-Grade Biosimilars | Anti-CD98 [EP3-1] |
| Research-Grade Biosimilars | Anti-DR5 [PRO95780 (Drozitumab)] |
| Research-Grade Biosimilars | Anti-EGFR [2F8 (Zalutumumab; HuMax-EGFR)] |
| Research-Grade Biosimilars | Anti-EGFR [C225 (Cetuximab)] |
| Research-Grade Biosimilars | Anti-EGFR [Matuzumab] |
| Research-Grade Biosimilars | Anti-EGFR domain III [h-R3 (Nimotuzumab)] |
| Research-Grade Biosimilars | Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
| Research-Grade Biosimilars | Anti-FAP alpha [BIBH1 (Sibrotuzumab, huF19)] |
| Research-Grade Biosimilars | Anti-Fas [R-125224] |
| Research-Grade Biosimilars | Anti-FOLR1 [Farletuzumab (MORAb-003; M3)] |
| Research-Grade Biosimilars | Anti-IgE [huMaE11 (Omalizumab)] |
| Research-Grade Biosimilars | Anti-IgE [TES-C21] |
| Research-Grade Biosimilars | Anti-IL-12/23 [ABT-874 (Briakinumab)] |
| Research-Grade Biosimilars | Anti-IL-15 [146B7 (Ordesekimab; AMG-714)] |
| Research-Grade Biosimilars | Anti-IL-20 [h15D2 (Fletikumab)] |
| Research-Grade Biosimilars | Anti-IL-2R [Daclizumab] |
| Research-Grade Biosimilars | Anti-IL-2R alpha (CD25) [Basiliximab] |
| Research-Grade Biosimilars | Anti-IL-5 [SB-240563 (Mepolizumab)] |
| Research-Grade Biosimilars | Anti-IL-5 [Sch 55700 (Reslizumab)] |
| Research-Grade Biosimilars | Anti-IL-6 receptor [rhPM-1 (Tocilizumab)] |
| Research-Grade Biosimilars | Anti-Integrin alpha 4 [Natalizumab] |
| Research-Grade Biosimilars | Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)] |
| Research-Grade Biosimilars | Anti-Lymphotoxin alpha [MLTA3698A (Pateclizumab)] |
| Research-Grade Biosimilars | Anti-Nerve growth factor [4D4 (Fulranumab; CNTO7309)] |
| Research-Grade Biosimilars | Anti-Omalizumab [B6] |
| Research-Grade Biosimilars | Anti-Omalizumab [E5] |
| Research-Grade Biosimilars | Anti-OX40L [R4930 (Oxelumab)] |
| Research-Grade Biosimilars | Anti-oxLDL [2-DO3] |
| Research-Grade Biosimilars | Anti-PD-1 [5C4.B8 (Nivolumab)] |
| Research-Grade Biosimilars | Anti-RSV [RSHZ19 (Felvizumab)] |
| Research-Grade Biosimilars | Anti-TAG-72 [Minretumomab (CC49 )] |
| Research-Grade Biosimilars | Anti-Tenascin [I-81C6 (Neuradiab)] |
| Research-Grade Biosimilars | Anti-TNF alpha [cA2 (Infliximab)] |
| Research-Grade Biosimilars | Anti-TNF alpha [CDP 571 (Humicade)] |
| Research-Grade Biosimilars | Anti-TNF alpha [D2E7 (Adalimumab)] |
| Research-Grade Biosimilars | Anti-TRP-1, gp75 [TA99] |
| Research-Grade Biosimilars | Anti-Tumor associated glycoprotein (TAG) 72 [B72.3 (Satumomab)] |
| Research-Grade Biosimilars | Anti-V(beta)3 TCR [JOVI.1] |
| Research-Grade Biosimilars | Anti-VEGF [Bevacizumab] |
| VivopureX™ Antibodies for In Vivo Research | Anti-OX40/CD134 [OX86] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG1 |
| VivopureX™ Antibodies for In Vivo Research | Agonism |
| VivopureX™ Antibodies for In Vivo Research | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg |
| VivopureX™ Antibodies for In Vivo Research | Anti-OX40/CD134 [OX86] |
| VivopureX™ Antibodies for In Vivo Research | Anti-PD-1 [RMP1-14] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG2a Fc Silent™ |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg |
| VivopureX™ Antibodies for In Vivo Research | Anti-CTLA-4 [9D9] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG2a |
| VivopureX™ Antibodies for In Vivo Research | Anti-CTLA-4 [9D9] |
| VivopureX™ Antibodies for In Vivo Research | Anti-GITR [DTA-1] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG2a |
| VivopureX™ Antibodies for In Vivo Research | Agonism |
| VivopureX™ Antibodies for In Vivo Research | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD25 [PC-61.5.3] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG2a |
| VivopureX™ Antibodies for In Vivo Research | Depletion |
| VivopureX™ Antibodies for In Vivo Research | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg |
| VivopureX™ Antibodies for In Vivo Research | Anti-TIGIT [1B4] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG1 |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg |
| VivopureX™ Antibodies for In Vivo Research | Anti-TIGIT [1B4] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG2a |
| VivopureX™ Antibodies for In Vivo Research | Anti-Lag3 [C9B7W] |
| VivopureX™ Antibodies for In Vivo Research | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD96 [6A6] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG2a Fc Silent™ |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg |
| VivopureX™ Antibodies for In Vivo Research | Anti-IL-10R [1B1.3a] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG2a Fc Silent™ |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg |
| VivopureX™ Antibodies for In Vivo Research | Anti-BTLA [HMBT-6B2] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG2a Fc Silent™ |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-Tim-4 [3A1] |
| VivopureX™ Antibodies for In Vivo Research | Mouse IgG2a Fc Silent™ |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-Tim-4 [5G3] |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-TIM-2 [RMT2-14] |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-Tim-1 [3B3] |
| VivopureX™ Antibodies for In Vivo Research | Anti-Tim-3 [2C12] |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD115/M-CSFR [AFS98] |
| VivopureX™ Antibodies for In Vivo Research | Anti-PD-L1 [10F.9G2] |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-PD-L1 [10F.9G2] |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-IFN-gamma receptor 1 [GR20] |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-VISTA [13F3] |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD20 [18B12] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD4 epitope A [YTS 177.9] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD4 epitope A [YTS 191.1] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD8 alpha/Lyt-2 [YTS 169.4] |
| VivopureX™ Antibodies for In Vivo Research | Anti-Ly6G [1A8] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD200R [OX131] |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-PD-L2 [TY25] |
| VivopureX™ Antibodies for In Vivo Research | Blocking |
| VivopureX™ Antibodies for In Vivo Research | Anti-Ly6G/Ly6C [RB6-8C5] |
| VivopureX™ Antibodies for In Vivo Research | Anti-Galectin 9 [RG9-35] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD153 [RM153] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD153 [RM153] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD155 [3F1] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD226 [10E5] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD45R [RA3-6B2] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD19 [6D5] |
| VivopureX™ Antibodies for In Vivo Research | Anti-HVEM [HMHV-1B18] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD27 [RM27-3E5] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD22 [OX-97] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD47 [mIAP301] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD80 [RM80] |
| VivopureX™ Antibodies for In Vivo Research | Anti-PD-1 [J43] |
| VivopureX™ Antibodies for In Vivo Research | Anti-PD-1 [29F.1A12] |
| VivopureX™ Antibodies for In Vivo Research | Anti-PD-1H [mam82] |
| VivopureX™ Antibodies for In Vivo Research | Anti-ICOS [7E.17G9] |
| VivopureX™ Antibodies for In Vivo Research | Anti-ICOS [7E.17G9] |
| VivopureX™ Antibodies for In Vivo Research | Anti-NK1.1 [PK-136] |
| VivopureX™ Antibodies for In Vivo Research | Anti-OX40/CD134 [OX86] |
| VivopureX™ Antibodies for In Vivo Research | Anti-NKG2D [CX-5] |
| VivopureX™ Antibodies for In Vivo Research | Anti-TIGIT [4D4] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD25 [2E4] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD25 [7D4] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD40L [MR1] |
| VivopureX™ Antibodies for In Vivo Research | Anti-Folate receptor beta [CL10] |
| VivopureX™ Antibodies for In Vivo Research | Anti-Galectin 9 [RG9-35] |
| VivopureX™ Antibodies for In Vivo Research | Anti-CD22 [OX-97] |
| Anti-Coronavirus Antibodies | Anti-Spike Protein [CV1] |
| Anti-Coronavirus Antibodies | Anti-Spike Protein (RBD) [CV30] |
| Anti-Coronavirus Antibodies | Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022] |
| Anti-Coronavirus Antibodies | Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)] |
| Anti-Coronavirus Antibodies | Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] |
| Anti-Coronavirus Antibodies | Anti-Spike protein (RBD) [Sb#14]] |
| Anti-Coronavirus Antibodies | Anti-Spike protein (RBD) [Sb#15] |
| Anti-Coronavirus Antibodies | Anti-Spike protein (RBD) [Sb#16] |
| Anti-Coronavirus Antibodies | Anti-Spike protein (RBD) [Sb#42] |
| Anti-Coronavirus Antibodies | Anti-Spike protein (RBD) [Sb#45] |
| Anti-Coronavirus Antibodies | Anti-Spike protein (RBD) [Sb#68] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S227] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S230] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S215] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S109] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S124] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S222] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S231] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S228] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S226] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S217] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S223] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S110] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [S225] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [4G2] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [5D3] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [6B1] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [5E4] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [1B5] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [4D4] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [11A] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [256] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [A11] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [F26G9] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [F26G10] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV S glycoprotein [F26G19] |
| Anti-Coronavirus Antibodies | Anti-MERS-CoV Spike Protein [D12] |
| Anti-Coronavirus Antibodies | Anti-MERS-CoV Spike Protein [4c2] |
| Anti-Coronavirus Antibodies | Anti-MERS-CoV Spike Protein [3B12] |
| Anti-Coronavirus Antibodies | Anti-MERS-CoV Spike Protein [M14D3] |
| Anti-Coronavirus Antibodies | Anti-MERS-CoV Spike Protein [1F8] |
| Anti-Coronavirus Antibodies | Anti-MERS-CoV Spike Protein [3A1] |
| Anti-Coronavirus Antibodies | Anti-Bovine coronavirus [SF-3E4] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV-2 and SARS-CoV nucleocapsid [mBG17] |
| Anti-Coronavirus Antibodies | Anti-SARS-CoV-2 nucleocapsid [mBG86] |
| Anti-Coronavirus Antibodies | Anti-Spike protein [EY6A] |
| Anti-Coronavirus Antibodies | Anti-Spike protein [SR4] |
| Anti-Coronavirus Antibodies | Anti-Spike protein [MR3] |
| Anti-Coronavirus Antibodies | Anti-Spike protein [Sb23] |
| Anti-Coronavirus Antibodies | Anti-Covid-19 & SARS-CoV Nucleocapsid [1C7C7] |
| Anti-Coronavirus Antibodies | Anti-Spike protein [Ty1] |
| Anti-Coronavirus Antibodies | Anti-Spike protein [MR17] |
| Antibodies to Epitope Tags | Anti-Biotin [mAb2] |
| Antibodies to Epitope Tags | Anti-Biotin [mAb7] |
| Antibodies to Epitope Tags | Anti-Biotin [muM33] |
| Antibodies to Epitope Tags | Anti-c-myc epitope tag [9E10] |
| Antibodies to Epitope Tags | Anti-CD56 [N901] |
| Antibodies to Epitope Tags | Anti-DDDDK-tag [M2.1] |
| Antibodies to Epitope Tags | Anti-EE-tag [3D5/EE_48.K] |
| Antibodies to Epitope Tags | Anti-GCN4 [C11L34] |
| Antibodies to Epitope Tags | Anti-GSTP1 [SAIC-22D-22] |
| Antibodies to Epitope Tags | Anti-HA Tag [16.43] |
| Antibodies to Epitope Tags | Anti-His tag (C-term) [3D5] |
| Antibodies to Epitope Tags | Anti-IL-5 [JES1-39D10] |
| Antibodies to Epitope Tags | Anti-MBP [MBP-7128] |
| Antibodies to Epitope Tags | Anti-MBP [MCS2] |
| Antibodies to Epitope Tags | Anti-MBP [sAb-11M] |
| Antibodies to Epitope Tags | Anti-MBP [sAb-70] |
| Antibodies to Epitope Tags | Anti-MBP [sAb-P1] |
| Antibodies to Epitope Tags | Anti-Notch 1 [2E6] |
| Antibodies to Epitope Tags | Anti-Podoplanin (MAP tag) [PMab-1] |
| Antibodies to Epitope Tags | Anti-Protein C [HPC-4] |
| Antibodies to Epitope Tags | Anti-RAP tag [PMab-2] |
| Antibodies to Epitope Tags | Anti-Rhodopsin [Rho 1D4] |
| Antibodies to Epitope Tags | Anti-Rim ABC protein [Rim 3F4] |
| Antibodies to Epitope Tags | Anti-Softag 1 [NT73] |
| Antibodies to Epitope Tags | Anti-Strep-Tag II [C23.21] |
| Antibodies to Epitope Tags | Anti-TK15 epitope tag [TK 15] |
| Antibodies to Epitope Tags | Anti-V5 epitope tag [SV5-P-K] |
| Immunotherapy Research Antibodies | OX86 |
| Immunotherapy Research Antibodies | OX131 |
| Immunotherapy Research Antibodies | YTS 169.4 |
| Immunotherapy Research Antibodies | YTS 177.9 |
| Immunotherapy Research Antibodies | YTS 191.1 |
| Immunotherapy Research Antibodies | 1A8 |
| Immunotherapy Research Antibodies | OX-97 |
| Immunotherapy Research Antibodies | RMP1-14 |
| Immunotherapy Research Antibodies | TY25 |
| Immunotherapy Research Antibodies | RM27-3E5 |
| Immunotherapy Research Antibodies | mam82 |
| Immunotherapy Research Antibodies | 9D9 |
| Immunotherapy Research Antibodies | HMHV-1B18 |
| Immunotherapy Research Antibodies | HMBT-6B2 |
| Immunotherapy Research Antibodies | RM80 |
| Immunotherapy Research Antibodies | RB6-8C5 |
| Immunotherapy Research Antibodies | RA3-6B2 |
| Immunotherapy Research Antibodies | 3B3 |
| Immunotherapy Research Antibodies | 2C12 |
| Immunotherapy Research Antibodies | 5G3 |
| Immunotherapy Research Antibodies | 3A1 |
| Immunotherapy Research Antibodies | DTA-1 |
| Immunotherapy Research Antibodies | RG9-35 |
| Immunotherapy Research Antibodies | RM153 |
| Immunotherapy Research Antibodies | RMT2-14 |
| Immunotherapy Research Antibodies | PC-61.5.3 |
| Immunotherapy Research Antibodies | GR20 |
| Immunotherapy Research Antibodies | 18B12 |
| Immunotherapy Research Antibodies | 1B4 |
| Immunotherapy Research Antibodies | C9B7W |
| Immunotherapy Research Antibodies | 6A6 |
| Immunotherapy Research Antibodies | 3F1 |
| Immunotherapy Research Antibodies | 1000000 |
| Immunotherapy Research Antibodies | J43 |
| Immunotherapy Research Antibodies | 10F.9G2 |
| Immunotherapy Research Antibodies | 13F3 |
| Immunotherapy Research Antibodies | 6D5 |
| Immunotherapy Research Antibodies | 1B1.3a |
| Immunotherapy Research Antibodies | AFS98 |
| Immunotherapy Research Antibodies | mIAP301 |
| Immunotherapy Research Antibodies | 29F.1A12 |
| Immunotherapy Research Antibodies | 145-2C11 |
| Immunotherapy Research Antibodies | OX7 |
| Immunotherapy Research Antibodies | 11B11 |
| Immunotherapy Research Antibodies | YTS 121.5.2 |
| Immunotherapy Research Antibodies | YTS 154.7.7.10 |
| Immunotherapy Research Antibodies | 7G6 |
| Immunotherapy Research Antibodies | alphaD11 |
| Immunotherapy Research Antibodies | MEL-14 |
| Immunotherapy Research Antibodies | MECA-367 |
| Immunotherapy Research Antibodies | M200 (Volociximab) |
| Immunotherapy Research Antibodies | Eculizumab |
| Immunotherapy Research Antibodies | Arcitumomab |
| Immunotherapy Research Antibodies | CAT-213 (Bertilimumab) |
| Immunotherapy Research Antibodies | MLN1202 (Plozalizumab, hu1D9) |
| Immunotherapy Research Antibodies | KW-0761 (Mogamulizumab) |
| Immunotherapy Research Antibodies | TRC105 (Carotuximab) |
| Immunotherapy Research Antibodies | hu1124 (Efalizumab) |
| Immunotherapy Research Antibodies | IDEC-131 (Toralizumab) |
| Immunotherapy Research Antibodies | 10F381 (rituximab) |
| Immunotherapy Research Antibodies | hL22 (Epratuzumab) |
| Immunotherapy Research Antibodies | YTH 906.9HL (Campath-6) |
| Immunotherapy Research Antibodies | BAFF (Tabalumab) |
| Immunotherapy Research Antibodies | OKT-3 (muromonab) |
| Immunotherapy Research Antibodies | hP67.6 (Gemtuzumab) |
| Immunotherapy Research Antibodies | SGN-33 (Lintuzumab) |
| Immunotherapy Research Antibodies | CE9.1 (Clenoliximab) |
| Immunotherapy Research Antibodies | MT310 |
| Immunotherapy Research Antibodies | YNB46.1.8 (Campath-9H) |
| Immunotherapy Research Antibodies | hu5c8 (Ruplizumab) |
| Immunotherapy Research Antibodies | 7E3 (Abciximab) |
| Immunotherapy Research Antibodies | GBR500 (Vatelizumab, TMC-2206) |
| Immunotherapy Research Antibodies | Alemtuzumab (Campath-1H) |
| Immunotherapy Research Antibodies | YTH 34.5-G2b (Campath-1G) |
| Immunotherapy Research Antibodies | IDEC-114 (Galiximab) |
| Immunotherapy Research Antibodies | EP3-1 |
| Immunotherapy Research Antibodies | PRO95780 (Drozitumab) |
| Immunotherapy Research Antibodies | Zalutumumab; HuMax-EGFR |
| Immunotherapy Research Antibodies | C225 (Cetuximab) |
| Immunotherapy Research Antibodies | Matuzumab |
| Immunotherapy Research Antibodies | h-R3 (Nimotuzumab) |
| Immunotherapy Research Antibodies | 4D5-8 (trastuzumab) |
| Immunotherapy Research Antibodies | BIBH1 (Sibrotuzumab, huF19) |
| Immunotherapy Research Antibodies | R-125224 |
| Immunotherapy Research Antibodies | Farletuzumab (MORAb-003; M3) |
| Immunotherapy Research Antibodies | huMaE11 (Omalizumab) |
| Immunotherapy Research Antibodies | ABT-874 (Briakinumab) |
| Immunotherapy Research Antibodies | h15D2 (Fletikumab) |
| Immunotherapy Research Antibodies | Daclizumab |
| Immunotherapy Research Antibodies | Basiliximab |
| Immunotherapy Research Antibodies | SB-240563 (Mepolizumab) |
| Immunotherapy Research Antibodies | Sch 55700 (Reslizumab) |
| Immunotherapy Research Antibodies | rhPM-1 (Tocilizumab) |
| Immunotherapy Research Antibodies | Natalizumab |
| Immunotherapy Research Antibodies | Vedolizumab (LDP-02) |
| Immunotherapy Research Antibodies | MLTA3698A (Pateclizumab) |
| Immunotherapy Research Antibodies | R4930 (Oxelumab) |
| Immunotherapy Research Antibodies | 2-DO3 |
| Immunotherapy Research Antibodies | 5C4.B8 (Nivolumab) |
| Immunotherapy Research Antibodies | RSHZ19 (Felvizumab) |
| Immunotherapy Research Antibodies | Minretumomab (CC49 ) |
| Immunotherapy Research Antibodies | I-81C6 (Neuradiab) |
| Immunotherapy Research Antibodies | cA2 (Infliximab) |
| Immunotherapy Research Antibodies | CDP 571 (Humicade) |
| Immunotherapy Research Antibodies | D2E7 (Adalimumab) |
| Immunotherapy Research Antibodies | TA99 |
| Immunotherapy Research Antibodies | B72.3 (Satumomab) |
| Immunotherapy Research Antibodies | JOVI.1 |
| Immunotherapy Research Antibodies | Bevacizumab |
| Immunotherapy Research Antibodies | LY2062430 (Solanezumab, hu266) |
| Immunotherapy Research Antibodies | LOB12.3 |
| Immunotherapy Research Antibodies | AT113-2 |
| Immunotherapy Research Antibodies | TKS-1 |
| Immunotherapy Research Antibodies | HMBT-6B2 |
| Immunotherapy Research Antibodies | LG.3A10 |
| Immunotherapy Research Antibodies | RM27-3E5 |
| Immunotherapy Research Antibodies | E18 |
| Immunotherapy Research Antibodies | D665 |
| Immunotherapy Research Antibodies | 45374 |
| Immunotherapy Research Antibodies | MR1 |
| Immunotherapy Research Antibodies | TAN 1-7 |
| Immunotherapy Research Antibodies | TAN1-6 |
| Immunotherapy Research Antibodies | RM80 |
| Immunotherapy Research Antibodies | PO.3 |
| Immunotherapy Research Antibodies | RM153 |
| Immunotherapy Research Antibodies | 6A6 |
| Immunotherapy Research Antibodies | 9H10 |
| Immunotherapy Research Antibodies | 9D9 |
| Immunotherapy Research Antibodies | RG9-35 |
| Immunotherapy Research Antibodies | DTA-1 |
| Immunotherapy Research Antibodies | YGITR 860.103.5 |
| Immunotherapy Research Antibodies | YGITR765 |
| Immunotherapy Research Antibodies | YGL386 |
| Immunotherapy Research Antibodies | HMHV-1B18 |
| Immunotherapy Research Antibodies | 7E.17G9 |
| Immunotherapy Research Antibodies | HK5.3 |
| Immunotherapy Research Antibodies | C9B7W |
| Immunotherapy Research Antibodies | OX86 |
| Immunotherapy Research Antibodies | OX-89 |
| Immunotherapy Research Antibodies | RMP1-14 |
| Immunotherapy Research Antibodies | mam82 |
| Immunotherapy Research Antibodies | MH5A |
| Immunotherapy Research Antibodies | YDC 127.1.1 |
| Immunotherapy Research Antibodies | TY25 |
| Immunotherapy Research Antibodies | PMab-1 |
| Immunotherapy Research Antibodies | 4D4 |
| Immunotherapy Research Antibodies | 1B4 |
| Immunotherapy Research Antibodies | 3B3 |
| Immunotherapy Research Antibodies | RMT2-14 |
| Immunotherapy Research Antibodies | 2C12 |
| Immunotherapy Research Antibodies | 5G3 |
| Immunotherapy Research Antibodies | 3A1 |
| Immunotherapy Research Antibodies | 6D5 x 145-2C11 |
| Immunotherapy Research Antibodies | 18B12 x 145-2C11 |
| Immunotherapy Research Antibodies | 9D9 x VHH-PD-L1 |
| Immunotherapy Research Antibodies | 9D9 x OX86 |
| Immunotherapy Research Antibodies | C225 (Cetuximab) x 145-2C11 |
| Immunotherapy Research Antibodies | L8A4 x 145-2C11 |
| Immunotherapy Research Antibodies | 4D5-8 (trastuzumab) x 145-2C11 |
| Immunotherapy Research Antibodies | 4D5-8 (trastuzumab) x OKT3 |
| Immunotherapy Research Antibodies | recombinant Cl:A3-1 x 145-2C11 |
| Immunotherapy Research Antibodies | 4-4-20 (enhanced) x 145-2C11 |
| Immunotherapy Research Antibodies | 4-4-20 (enhanced) x VHH-PD-L1 |
| Immunotherapy Research Antibodies | 4-4-20 (enhanced) x A4 |
| Immunotherapy Research Antibodies | TA99 x 145-2C11 |
| Immunotherapy Research Antibodies | TA99 x A4 |
| Immunotherapy Research Antibodies | TA99 x OX86 |
| Immunotherapy Research Antibodies | OX-90 |
| Immunotherapy Research Antibodies | RMP1-14 |
| Immunotherapy Research Antibodies | RMP1-15 |
| Immunotherapy Research Antibodies | 10F.9G2 x 145-2C11 |
| Immunotherapy Research Antibodies | YDC 127.1.1 |
| Immunotherapy Research Antibodies | 10F.9G2 x OX86 |
| Immunotherapy Research Antibodies | 10F.9G2 x D665 |
| Immunotherapy Research Antibodies | mam82 |
| Immunotherapy Research Antibodies | 4D4 |
| Immunotherapy Research Antibodies | CX-5 x 145-2C11 |
| Immunotherapy Research Antibodies | huA33 |
| Immunotherapy Research Antibodies | AF5 |
| Immunotherapy Research Antibodies | 32C8_71 |
| Immunotherapy Research Antibodies | G3-F11 |
| Immunotherapy Research Antibodies | bcl-2/100 |
| Immunotherapy Research Antibodies | BBM.1 |
| Immunotherapy Research Antibodies | bcl-2/124 |
| Immunotherapy Research Antibodies | BrE-3 |
| Immunotherapy Research Antibodies | FWP51 |
| Immunotherapy Research Antibodies | 196-14 |
| Immunotherapy Research Antibodies | OC125-3.11 |
| Immunotherapy Research Antibodies | VK-8-1.9 |
| Immunotherapy Research Antibodies | 4A6 |
| Immunotherapy Research Antibodies | 4G2 |
| Immunotherapy Research Antibodies | C242 |
| Immunotherapy Research Antibodies | CA50Ab01 |
| Immunotherapy Research Antibodies | Mab231 |
| Immunotherapy Research Antibodies | Arcitumomab |
| Immunotherapy Research Antibodies | A5B7 |
| Immunotherapy Research Antibodies | CD155.16 |
| Immunotherapy Research Antibodies | scFv1 |
| Immunotherapy Research Antibodies | scFv3 |
| Immunotherapy Research Antibodies | SKII.4 |
| Immunotherapy Research Antibodies | B4 |
| Immunotherapy Research Antibodies | BW431/26 |
| Immunotherapy Research Antibodies | CH1A1A (2F1, CH1A1A-2F1) |
| Immunotherapy Research Antibodies | EB-011 |
| Immunotherapy Research Antibodies | EB-022 |
| Immunotherapy Research Antibodies | T84.66 |
| Immunotherapy Research Antibodies | HL1925 |
| Immunotherapy Research Antibodies | Mu-9 |
| Immunotherapy Research Antibodies | 25B6 |
| Immunotherapy Research Antibodies | OV-TL 12/30 |
| Immunotherapy Research Antibodies | TS1 |
| Immunotherapy Research Antibodies | DH8.3 |
| Immunotherapy Research Antibodies | 2F8 (Zalutumumab; HuMax-EGFR) |
| Immunotherapy Research Antibodies | 2224 |
| Immunotherapy Research Antibodies | 528 |
| Immunotherapy Research Antibodies | C225 (Cetuximab) |
| Immunotherapy Research Antibodies | cet.Hum (Cetuximab – humanized; hC225) |
| Immunotherapy Research Antibodies | EGFR1 |
| Immunotherapy Research Antibodies | L2 1C |
| Immunotherapy Research Antibodies | L3 11D |
| Immunotherapy Research Antibodies | Matuzumab |
| Immunotherapy Research Antibodies | S3 12D |
| Immunotherapy Research Antibodies | S4 10H |
| Immunotherapy Research Antibodies | h-R3 (Nimotuzumab) |
| Immunotherapy Research Antibodies | L8A4 |
| Immunotherapy Research Antibodies | scFv78 |
| Immunotherapy Research Antibodies | B38.1 |
| Immunotherapy Research Antibodies | 4D5-8 (trastuzumab) |
| Immunotherapy Research Antibodies | SAIC-02A-7 |
| Immunotherapy Research Antibodies | FU-MK-1 |
| Immunotherapy Research Antibodies | Clone 29 |
| Immunotherapy Research Antibodies | MBM-12 |
| Immunotherapy Research Antibodies | MBM-14 |
| Immunotherapy Research Antibodies | AbAb-GPC1 |
| Immunotherapy Research Antibodies | 4D5 |
| Immunotherapy Research Antibodies | C7b |
| Immunotherapy Research Antibodies | ML3-9 (C6ML3-9) |
| Immunotherapy Research Antibodies | SER4 |
| Immunotherapy Research Antibodies | A5 |
| Immunotherapy Research Antibodies | B6 (HER4.B6) |
| Immunotherapy Research Antibodies | KC4G3 |
| Immunotherapy Research Antibodies | 1C1 |
| Immunotherapy Research Antibodies | 6F4 |
| Immunotherapy Research Antibodies | AbAbKRAS01 |
| Immunotherapy Research Antibodies | D113 |
| Immunotherapy Research Antibodies | 3S193 |
| Immunotherapy Research Antibodies | BR96 |
| Immunotherapy Research Antibodies | H18A |
| Immunotherapy Research Antibodies | H3 |
| Immunotherapy Research Antibodies | FMC-9 |
| Immunotherapy Research Antibodies | 21B4 |
| Immunotherapy Research Antibodies | 45986 |
| Immunotherapy Research Antibodies | C10 |
| Immunotherapy Research Antibodies | IC14-30 |
| Immunotherapy Research Antibodies | K1 |
| Immunotherapy Research Antibodies | 45950 |
| Immunotherapy Research Antibodies | 41-28 |
| Immunotherapy Research Antibodies | E29 |
| Immunotherapy Research Antibodies | HMFG1 (1.10.F3) |
| Immunotherapy Research Antibodies | HMFG2 |
| Immunotherapy Research Antibodies | Mc5 |
| Immunotherapy Research Antibodies | PAM4 |
| Immunotherapy Research Antibodies | SM3 |
| Immunotherapy Research Antibodies | E1-7E2 |
| Immunotherapy Research Antibodies | E2-4F6 |
| Immunotherapy Research Antibodies | OV-TL3 |
| Immunotherapy Research Antibodies | TP-1 |
| Immunotherapy Research Antibodies | TP-3 |
| Immunotherapy Research Antibodies | Y13-238 |
| Immunotherapy Research Antibodies | DWP |
| Immunotherapy Research Antibodies | KGH-R1 |
| Immunotherapy Research Antibodies | PAb421 |
| Immunotherapy Research Antibodies | CTM01 |
| Immunotherapy Research Antibodies | 8G8F5 |
| Immunotherapy Research Antibodies | scFv B8 |
| Immunotherapy Research Antibodies | 11d1e5E10 |
| Immunotherapy Research Antibodies | 8C12 |
| Immunotherapy Research Antibodies | J591 |
| Immunotherapy Research Antibodies | S1-61 |
| Immunotherapy Research Antibodies | 1C8 |
| Immunotherapy Research Antibodies | SP15 |
| Immunotherapy Research Antibodies | Minretumomab (CC49) |
| Immunotherapy Research Antibodies | I-81C6 (Neuradiab) |
| Immunotherapy Research Antibodies | 237mAb |
| Immunotherapy Research Antibodies | scFv40 |
| Immunotherapy Research Antibodies | scFv69 |
| Immunotherapy Research Antibodies | TA99 |
| Immunotherapy Research Antibodies | B72.3 (Satumomab) |
| Immunotherapy Research Antibodies | 2D10 |
| Immunotherapy Research Antibodies | 3F10 |
| Immunotherapy Research Antibodies | 3G6 |
| Immunotherapy Research Antibodies | TK8-14 |
| Neuroscience Research Antibodies | Anti-14G2a [1A7] |
| Neuroscience Research Antibodies | Anti-3K11 idiotype [AI-K11B] |
| Neuroscience Research Antibodies | Anti-6G1 idiotype [AI-G1] |
| Neuroscience Research Antibodies | Anti-acetylcholine receptor [mAb198] |
| Neuroscience Research Antibodies | Anti-Alpha-Synuclein [NAC32] |
| Neuroscience Research Antibodies | Anti-AMIGO-1 [AC27] |
| Neuroscience Research Antibodies | Anti-AMIGO-1 [AC50] |
| Neuroscience Research Antibodies | Anti-Amyloid beta (aa 4-10) [WO2] |
| Neuroscience Research Antibodies | Anti-Amyloid Beta [21F12] |
| Neuroscience Research Antibodies | Anti-amyloid beta [6E10] |
| Neuroscience Research Antibodies | Anti-Ankyrin-G (staining) [N106/43] |
| Neuroscience Research Antibodies | Anti-Ankyrin-R [N388A/10] |
| Neuroscience Research Antibodies | Anti-APP [2C5] |
| Neuroscience Research Antibodies | Anti-APP [2F9] |
| Neuroscience Research Antibodies | Anti-Arl13b [N295B/66R] |
| Neuroscience Research Antibodies | Anti-Ataxin-1, 11NQ [N76/3] |
| Neuroscience Research Antibodies | Anti-Ataxin-1, 11NQ [N76/8] |
| Neuroscience Research Antibodies | Anti-ATP7A [L60/4] |
| Neuroscience Research Antibodies | Anti-BACE2 [1/ 9 ] |
| Neuroscience Research Antibodies | Anti-BK beta4 K+ channel [L18A/3R] |
| Neuroscience Research Antibodies | Anti-Botch [N116/14] |
| Neuroscience Research Antibodies | Anti-Botulinum neurotoxin [BotFab 5] |
| Neuroscience Research Antibodies | Anti-Botulinum neurotoxin [MCS6-27] |
| Neuroscience Research Antibodies | Anti-CART [AH36] |
| Neuroscience Research Antibodies | Anti-Cav3.1 Ca2+ channel [N178A/9.1] |
| Neuroscience Research Antibodies | Anti-Cavbeta1 Ca2+ channel [N7/18.1] |
| Neuroscience Research Antibodies | Anti-Cavbeta2 Ca2+ channel [N8B/1R] |
| Neuroscience Research Antibodies | Anti-CD10 [FR4D11] |
| Neuroscience Research Antibodies | Anti-CD11b [M1/70] |
| Neuroscience Research Antibodies | Anti-CD127 [1A11] |
| Neuroscience Research Antibodies | Anti-CD127 [6A3] |
| Neuroscience Research Antibodies | Anti-CD39 [R22] |
| Neuroscience Research Antibodies | Anti-CD40L [AT161-10] |
| Neuroscience Research Antibodies | Anti-CD40L [AT161-8] |
| Neuroscience Research Antibodies | Anti-CD73 [YDBYT 208.3] |
| Neuroscience Research Antibodies | Anti-CDCrel-1 [SP18] |
| Neuroscience Research Antibodies | Anti-Ciguatoxin CTX3C [10C9] |
| Neuroscience Research Antibodies | Anti-Ciguatoxin CTX3C [1C49] |
| Neuroscience Research Antibodies | Anti-Clcn4 [N222/6] |
| Neuroscience Research Antibodies | Anti-Cn2 toxin [6009F] |
| Neuroscience Research Antibodies | Anti-Cn2 toxin [BCF2] |
| Neuroscience Research Antibodies | Anti-Co-Rest/RCOR1 [K72/8R] |
| Neuroscience Research Antibodies | Anti-Cocaine [15A10] |
| Neuroscience Research Antibodies | Anti-Cocaine [3B2] |
| Neuroscience Research Antibodies | Anti-Cocaine [4F1] |
| Neuroscience Research Antibodies | Anti-Cocaine [7A1] |
| Neuroscience Research Antibodies | Anti-Cocaine [GNC92H2] |
| Neuroscience Research Antibodies | Anti-Cocaine [K2-3] |
| Neuroscience Research Antibodies | Anti-Cocaine [M82G2] |
| Neuroscience Research Antibodies | Anti-Crotoxin [CTX-scFv8] |
| Neuroscience Research Antibodies | Anti-Ctip2 [25B6] |
| Neuroscience Research Antibodies | Anti-disialoganglioside 2 [7A4] |
| Neuroscience Research Antibodies | Anti-DLX1 Transcription Factor [L43/40] |
| Neuroscience Research Antibodies | Anti-DNMT3L [N117/9.5] |
| Neuroscience Research Antibodies | Anti-Doc2b [N150/21.3] |
| Neuroscience Research Antibodies | Anti-Dopamine D3 receptor [N331/19] |
| Neuroscience Research Antibodies | Anti-endophilin-A2 [K51/1] |
| Neuroscience Research Antibodies | Anti-FGF12/FHF1 [N94/17] |
| Neuroscience Research Antibodies | Anti-FGF13/FHF2 [N91/27.1] |
| Neuroscience Research Antibodies | Anti-Flrt3 [N353/13] |
| Neuroscience Research Antibodies | Anti-Foxi3 [N359/28] |
| Neuroscience Research Antibodies | Anti-GABA(A)R, Beta1 [N96/55.3] |
| Neuroscience Research Antibodies | Anti-GABA(A)R, Delta [N151/3.3] |
| Neuroscience Research Antibodies | Anti-GABA(B)R [N93A/49.2] |
| Neuroscience Research Antibodies | Anti-GABA(B)R2 [N81/37.1] |
| Neuroscience Research Antibodies | Anti-GABA-A Receptor, Gamma 2 Subunit [10F10-C1-B8] |
| Neuroscience Research Antibodies | Anti-GABA-A-R-Alpha5 [N415/24R] |
| Neuroscience Research Antibodies | Anti-GABAR [1F4] |
| Neuroscience Research Antibodies | Anti-Galanin [4B3] |
| Neuroscience Research Antibodies | Anti-Galanin [5B4] |
| Neuroscience Research Antibodies | Anti-Gephyrin [GC1] |
| Neuroscience Research Antibodies | Anti-Gephyrin [GC52] |
| Neuroscience Research Antibodies | Anti-Gephyrin [GC83] |
| Neuroscience Research Antibodies | Anti-Gephyrin [GC92] |
| Neuroscience Research Antibodies | Anti-Gephyrin [GS41] |
| Neuroscience Research Antibodies | Anti-Gephyrin [GS8] |
| Neuroscience Research Antibodies | Anti-GFAP R416WT [N206B/9] |
| Neuroscience Research Antibodies | Anti-GFP [N86/38.1] |
| Neuroscience Research Antibodies | Anti-GIT2 [N83/48R] |
| Neuroscience Research Antibodies | Anti-GluA1/GluR1 glutamate receptor [N355/1] |
| Neuroscience Research Antibodies | Anti-GluCl [GluCl] |
| Neuroscience Research Antibodies | Anti-GluN2B/NR2B glutamate receptor [N59/36.1] |
| Neuroscience Research Antibodies | Anti-haloperidol [Clone A] |
| Neuroscience Research Antibodies | Anti-haloperidol [Clone D] |
| Neuroscience Research Antibodies | Anti-HCN1 [N70/28] |
| Neuroscience Research Antibodies | Anti-HCN4 [N114/10.1] |
| Neuroscience Research Antibodies | Anti-Homer1 [HC20] |
| Neuroscience Research Antibodies | Anti-Homer1 [HC25] |
| Neuroscience Research Antibodies | Anti-Homer1 [HC87] |
| Neuroscience Research Antibodies | Anti-Homer1 [HC89] |
| Neuroscience Research Antibodies | Anti-Homer1 [HS22] |
| Neuroscience Research Antibodies | Anti-Homer1 [HS38] |
| Neuroscience Research Antibodies | Anti-Homer1 [HS63] |
| Neuroscience Research Antibodies | Anti-Homer1 [HS69] |
| Neuroscience Research Antibodies | Anti-Homer1 [HS89] |
| Neuroscience Research Antibodies | Anti-iC3b [6G1] |
| Neuroscience Research Antibodies | Anti-INPP4b [N171/17.4] |
| Neuroscience Research Antibodies | Anti-Insulin-degrading Enzyme [Fab-IDE] |
| Neuroscience Research Antibodies | Anti-IQGAP2 [A2] |
| Neuroscience Research Antibodies | Anti-IRSp53 [IC65] |
| Neuroscience Research Antibodies | Anti-JIP-2/IB-2 [N135/37.2] |
| Neuroscience Research Antibodies | Anti-KA2 kainate receptor [N279B/27R] |
| Neuroscience Research Antibodies | Anti-KChIP3 K+ channel [K66/38] |
| Neuroscience Research Antibodies | Anti-KCNT1/Slo2.2/Slack K+ channel [N3/26R] |
| Neuroscience Research Antibodies | Anti-KCNT2/Slo2.1/Slick K+ channel [N11/33] |
| Neuroscience Research Antibodies | Anti-KCNU1/Slo3 maxi-K+ channel [N2/16] |
| Neuroscience Research Antibodies | Anti-Ketamine [4A1] |
| Neuroscience Research Antibodies | Anti-Ketamine [6B2] |
| Neuroscience Research Antibodies | Anti-Kir2.2 K+ [N124B/38R] |
| Neuroscience Research Antibodies | Anti-Kirrel3 short isoform 3 [N320/48R] |
| Neuroscience Research Antibodies | Anti-Kirrel3, short and long [N321C/49] |
| Neuroscience Research Antibodies | Anti-Kv1.1 K+ Channel [K20/78] |
| Neuroscience Research Antibodies | Anti-Kv1.1 K+ Channel Extracellular Domain [K36/15] |
| Neuroscience Research Antibodies | Anti-Kv1.2 K+ Channel [K14/16] |
| Neuroscience Research Antibodies | Anti-Kv1.4 K+ Channel [K13/31] |
| Neuroscience Research Antibodies | Anti-Kv1.5 K+ channel [K7/45R] |
| Neuroscience Research Antibodies | Anti-Kv1.6 K+ channel [K19/36R] |
| Neuroscience Research Antibodies | Anti-Kv2.1 K+ Channel [K89/34] |
| Neuroscience Research Antibodies | Anti-Kv2.1 K+ Channel Ectodomain [K39/25] |
| Neuroscience Research Antibodies | Anti-Kv2.1 K+ channel pS603 [L61/14R] |
| Neuroscience Research Antibodies | Anti-Kv2.1 K+ channel α subunit [D3/71] |
| Neuroscience Research Antibodies | Anti-Kv3.1b K+ channel [N16B/8] |
| Neuroscience Research Antibodies | Anti-Kv4.2 K+ Channel Ectodomain [K57/1] |
| Neuroscience Research Antibodies | Anti-Kv4.2 potassium channel [L28/4R] |
| Neuroscience Research Antibodies | Anti-Kv4.3 K+ Channel [K75/41] |
| Neuroscience Research Antibodies | Anti-Kvbeta K+ Channel [K25/73] |
| Neuroscience Research Antibodies | Anti-Kvbeta1.1 K+ channel [K9/40R] |
| Neuroscience Research Antibodies | Anti-Kvbeta2 K+ Channel [K17/70] |
| Neuroscience Research Antibodies | Anti-Laforin [N84/37.1] |
| Neuroscience Research Antibodies | Anti-LRP4 (cytoplasmic) [N164/6.1] |
| Neuroscience Research Antibodies | Anti-LRRK1 [N341/37] |
| Neuroscience Research Antibodies | Anti-LRRTM4 [N205B/22] |
| Neuroscience Research Antibodies | Anti-Mad3 [N129A/6R] |
| Neuroscience Research Antibodies | Anti-Malin [N85/18.1] |
| Neuroscience Research Antibodies | Anti-MAP-2 [AA5 (AP18)] |
| Neuroscience Research Antibodies | Anti-MCSP [LC007 (M4-3-ML2)] |
| Neuroscience Research Antibodies | Anti-MESD [N88/12.1] |
| Neuroscience Research Antibodies | Anti-metarhodopsin-I [K42-41L] |
| Neuroscience Research Antibodies | Anti-Methamphetamine [6H4 S93T] |
| Neuroscience Research Antibodies | Anti-Mitofusin-1 [N111/24R] |
| Neuroscience Research Antibodies | Anti-Mitofusin-2 [N153/5.1] |
| Neuroscience Research Antibodies | Anti-MMACHC [N230/21] |
| Neuroscience Research Antibodies | Anti-MMP9 [L51/82R] |
| Neuroscience Research Antibodies | Anti-MOG [8.18-C5] |
| Neuroscience Research Antibodies | Anti-MOG [M26] |
| Neuroscience Research Antibodies | Anti-MOG [M3-24] |
| Neuroscience Research Antibodies | Anti-MOG [M3-31] |
| Neuroscience Research Antibodies | Anti-MOG [M3-8] |
| Neuroscience Research Antibodies | Anti-MOG [M38] |
| Neuroscience Research Antibodies | Anti-MOG [M45] |
| Neuroscience Research Antibodies | Anti-Morphine [12D4] |
| Neuroscience Research Antibodies | Anti-Morphine [3K11] |
| Neuroscience Research Antibodies | Anti-Morphine [6G1] |
| Neuroscience Research Antibodies | Anti-Morphine [9B1] |
| Neuroscience Research Antibodies | Anti-Morphine [M86] |
| Neuroscience Research Antibodies | Anti-Morphine [MOR131 (MOR131.5.13)] |
| Neuroscience Research Antibodies | Anti-Morphine [MOR158 (MOR158.1.3)] |
| Neuroscience Research Antibodies | Anti-Mortalin/GRP75 [N52A/42.1] |
| Neuroscience Research Antibodies | Anti-Myelin basic protein [845D3] |
| Neuroscience Research Antibodies | Anti-Myelin basic protein [B5V6] |
| Neuroscience Research Antibodies | Anti-Myelin basic protein [E2] |
| Neuroscience Research Antibodies | Anti-Myelin basic protein [F11] |
| Neuroscience Research Antibodies | Anti-Myelin basic protein [F23C6] |
| Neuroscience Research Antibodies | Anti-Myelin basic protein [F28C4] |
| Neuroscience Research Antibodies | Anti-Myelin oligodendrocyte glycoprotein [M3-24] |
| Neuroscience Research Antibodies | Anti-Myelin oligodendrocyte glycoprotein [M45] |
| Neuroscience Research Antibodies | Anti-Nav1.1 Na+ channel [K74/71] |
| Neuroscience Research Antibodies | Anti-Navbeta4 Na+ channel [N168/6.3] |
| Neuroscience Research Antibodies | Anti-Nerve growth factor (beta) [Ig 30] |
| Neuroscience Research Antibodies | Anti-Neural/glial antigen 2 (NG2) [9.2.27] |
| Neuroscience Research Antibodies | Anti-Neuregulin-HBD (Heparin binding domain, Type I/II) [N120A/9.1] |
| Neuroscience Research Antibodies | Anti-Neurexin-1-Beta [N170A/1.1] |
| Neuroscience Research Antibodies | Anti-Neurofilament light [MS-C2] |
| Neuroscience Research Antibodies | Anti-Neuroligin-1 [N97A/31] |
| Neuroscience Research Antibodies | Anti-Neuroligin-3 [N110/29.4] |
| Neuroscience Research Antibodies | Anti-Neuroligin-4 [N98/7R] |
| Neuroscience Research Antibodies | Anti-Neurotoxin AahII [4C1] |
| Neuroscience Research Antibodies | Anti-NGL-3/LRRC4B [N51/6.2] |
| Neuroscience Research Antibodies | Anti-NgR1 [M5] |
| Neuroscience Research Antibodies | Anti-NgR2 [P14] |
| Neuroscience Research Antibodies | Anti-Nicotine [F018] |
| Neuroscience Research Antibodies | Anti-Nicotine [NIC9D9] |
| Neuroscience Research Antibodies | Anti-Nitric Oxide Synthase [3F7-B11-B5] |
| Neuroscience Research Antibodies | Anti-NSD3 [N348/82] |
| Neuroscience Research Antibodies | Anti-Olig1 [N149/25.1] |
| Neuroscience Research Antibodies | Anti-Oligodendrocyte-specific surface antigen [SCH94.03] |
| Neuroscience Research Antibodies | Anti-Pan-Ankyrin Pan [N388A/60] |
| Neuroscience Research Antibodies | Anti-Pan-FHF-A (Homo sapiens) [N235/22] |
| Neuroscience Research Antibodies | Anti-Pan-Nav channel [K58/35] |
| Neuroscience Research Antibodies | Anti-Pan-Nav1 Na+ channel [N419/40] |
| Neuroscience Research Antibodies | Anti-Pan-Nav1 Na+ channel [N419/78] |
| Neuroscience Research Antibodies | Anti-Pan-QKI [N147/6.1] |
| Neuroscience Research Antibodies | Anti-Pan-SAPAP [N127/31.1] |
| Neuroscience Research Antibodies | Anti-Pan-Shank Pan [N23B/49] |
| Neuroscience Research Antibodies | Anti-Pannexin-2 [N121A/31R] |
| Neuroscience Research Antibodies | Anti-PARIS/ZNF746 [N196/16] |
| Neuroscience Research Antibodies | Anti-Peripherin [H184] |
| Neuroscience Research Antibodies | Anti-Phencyclidine [6B5] |
| Neuroscience Research Antibodies | Anti-Phospho-Tau [AT8] |
| Neuroscience Research Antibodies | Anti-Phospho-Tau [pT231/pS235_1] |
| Neuroscience Research Antibodies | Anti-PICK1 [L20/8] |
| Neuroscience Research Antibodies | Anti-Polyglutamine repeats [3B5H10] |
| Neuroscience Research Antibodies | Anti-Polysialic acid [735] |
| Neuroscience Research Antibodies | Anti-Prion [3F4] |
| Neuroscience Research Antibodies | Anti-Prion Protein [110] |
| Neuroscience Research Antibodies | Anti-Prion Protein [31C6] |
| Neuroscience Research Antibodies | Anti-Prion protein [D18] |
| Neuroscience Research Antibodies | Anti-Prion protein [VRQ14] |
| Neuroscience Research Antibodies | Anti-PrP [P-clone] |
| Neuroscience Research Antibodies | Anti-PrPSc [6H10] |
| Neuroscience Research Antibodies | Anti-PSD-95 [K28/43] |
| Neuroscience Research Antibodies | Anti-QKI-5 [N195A/16] |
| Neuroscience Research Antibodies | Anti-QKI-6 [N182/17.1] |
| Neuroscience Research Antibodies | Anti-REEP1/2 [N326D/29] |
| Neuroscience Research Antibodies | Anti-RGS14 [N133/21.2] |
| Neuroscience Research Antibodies | Anti-ROBO-1 [B2212A] |
| Neuroscience Research Antibodies | Anti-S100A5 [N176A/35.1] |
| Neuroscience Research Antibodies | Anti-SAP97 scaffold protein [K64/15] |
| Neuroscience Research Antibodies | Anti-SAPAP2 [SC27] |
| Neuroscience Research Antibodies | Anti-SAPAP2 [SS1] |
| Neuroscience Research Antibodies | Anti-SAPAP2 [SS2] |
| Neuroscience Research Antibodies | Anti-SAPAP2 [SS32] |
| Neuroscience Research Antibodies | Anti-SAPAP2 [SS3] |
| Neuroscience Research Antibodies | Anti-SAPAP2 [SS41] |
| Neuroscience Research Antibodies | Anti-SAPAP2 [SS44] |
| Neuroscience Research Antibodies | Anti-SAPAP2 [SS80] |
| Neuroscience Research Antibodies | Anti-SAPAP2 [SS88] |
| Neuroscience Research Antibodies | Anti-SCG10/Stathmin-2 [L5/1R] |
| Neuroscience Research Antibodies | Anti-SERT [8B6] |
| Neuroscience Research Antibodies | Anti-Shank3 [N69/46R] |
| Neuroscience Research Antibodies | Anti-Sialoganglioside [A2B5] |
| Neuroscience Research Antibodies | Anti-Slo1/BKAlpha maxi-K+ channel [L6/23] |
| Neuroscience Research Antibodies | Anti-SNAP-25 [SP12] |
| Neuroscience Research Antibodies | Anti-Snapin/SNAPAP [L8/15R] |
| Neuroscience Research Antibodies | Anti-Sodium-dependent noradrenaline transporter [2-3B2] |
| Neuroscience Research Antibodies | Anti-Sodium-dependent noradrenaline transporter [3-6C1] |
| Neuroscience Research Antibodies | Anti-Sodium-dependent serotonin transporter [1-4A5] |
| Neuroscience Research Antibodies | Anti-Spectrin [RG/26] |
| Neuroscience Research Antibodies | Anti-Stonin-2 [N346/9] |
| Neuroscience Research Antibodies | Anti-SUR1 [N289/16] |
| Neuroscience Research Antibodies | Anti-SUR2B [N323B/20] |
| Neuroscience Research Antibodies | Anti-SVOP [N356/23] |
| Neuroscience Research Antibodies | Anti-Synaptophysin [SP15] |
| Neuroscience Research Antibodies | Anti-Synaptotagmin-10 [N269/73] |
| Neuroscience Research Antibodies | Anti-Synaptotagmin-12 [N277/7] |
| Neuroscience Research Antibodies | Anti-Synaptotagmin-3 [N278/19] |
| Neuroscience Research Antibodies | Anti-SynCAM4 [N244/5] |
| Neuroscience Research Antibodies | Anti-SynDIG1 [L42/17] |
| Neuroscience Research Antibodies | Anti-Syntaxin-1A [SP6] |
| Neuroscience Research Antibodies | Anti-Tau [MN423] |
| Neuroscience Research Antibodies | Anti-Tau [PC1C6] |
| Neuroscience Research Antibodies | Anti-tau [Tau-5] |
| Neuroscience Research Antibodies | Anti-Tau Oligomeric complex [TOC1] |
| Neuroscience Research Antibodies | Anti-Tetanus toxin [G6] |
| Neuroscience Research Antibodies | Anti-Tetrodotoxin [T53] |
| Neuroscience Research Antibodies | Anti-THC [THC] |
| Neuroscience Research Antibodies | Anti-Thy1.1 [OX7] |
| Neuroscience Research Antibodies | Anti-TNFR2 [5E6] |
| Neuroscience Research Antibodies | Anti-TRIP8b (constant) [N212/17] |
| Neuroscience Research Antibodies | Anti-TRIP8b (exon 1a/5) [N291C/22] |
| Neuroscience Research Antibodies | Anti-TRIP8b (exon 4) [N212/3] |
| Neuroscience Research Antibodies | Anti-TrkA [MNAC13] |
| Neuroscience Research Antibodies | Anti-TRKB [C2] |
| Neuroscience Research Antibodies | Anti-TrkB.T1 [FH1D12] |
| Neuroscience Research Antibodies | Anti-TRPML3/Mucolipin-3 [N268/19] |
| Neuroscience Research Antibodies | Anti-TSY-LeuT [6A10] |
| Neuroscience Research Antibodies | Anti-VAMP [SP10] |
| Neuroscience Research Antibodies | Anti-Versican [N351/23] |
| Neuroscience Research Antibodies | Anti-VGlut1 [N28/9] |
| Neuroscience Research Antibodies | Anti-VGlut2 [N29/29] |
| Neuroscience Research Antibodies | Anti-VGlut3 [N34/34.2] |
| Neuroscience Research Antibodies | Anti-Vitamin D binding protein [6A2] |
| Neuroscience Research Antibodies | Anti-WAVE-1 [K91/36] |
| Neuroscience Research Antibodies | Anti-Y108F-LeuT [2B12] |
| Neuroscience Research Antibodies | Anti-ZNF423 [N328B/37R] |
| Recombinant Isotype Controls | Anti-Beta-galactosidase[13R4] |
| Recombinant Isotype Controls | Anti-Beta-galactosidase[GL117] |
| Recombinant Isotype Controls | Anti-Fluorescein[4-4-20(enhanced)] |
| Recombinant Isotype Controls | Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] |
| Recombinant Isotype Controls | Anti-Unknown Specificity(lsotype control) [MOPC-21] |
| Tumor Marker Antigens | Anti-A33 [huA33] |
| Tumor Marker Antigens | Anti-Alpha-fetoprotein (AFP) [AF5] |
| Tumor Marker Antigens | Anti-Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 [32C8_71] |
| Tumor Marker Antigens | Anti-Aspartate beta-hydroxylase [G3-F11] |
| Tumor Marker Antigens | Anti-BCL2 [bcl-2/100] |
| Tumor Marker Antigens | Anti-Beta-2 microglobulin [BBM.1] |
| Tumor Marker Antigens | Anti-BLC2 [bcl-2/124] |
| Tumor Marker Antigens | Anti-Breast Epithelial Mucin [BrE-3] |
| Tumor Marker Antigens | Anti-c-erbB-2 [FWP51] |
| Tumor Marker Antigens | Anti-CA125 [196-14] |
| Tumor Marker Antigens | Anti-CA125 [OC125-3.11] |
| Tumor Marker Antigens | Anti-CA125 [VK-8-1.9] |
| Tumor Marker Antigens | Anti-CA19-9 [4A6] |
| Tumor Marker Antigens | Anti-CA19-9 [4G2] |
| Tumor Marker Antigens | Anti-CA242 [C242] |
| Tumor Marker Antigens | Anti-CA242 [WT 1-31] |
| Tumor Marker Antigens | Anti-CA50 [CA50Ab01] |
| Tumor Marker Antigens | Anti-Canine Lymphoma [Mab231] |
| Tumor Marker Antigens | Anti-carcinoembryonic antigen (CEA) [Arcitumomab] |
| Tumor Marker Antigens | Anti-carcinoembryonic antigen [A5B7] |
| Tumor Marker Antigens | Anti-CD155 [CD155.16 ] |
| Tumor Marker Antigens | Anti-CD155 [scFv1] |
| Tumor Marker Antigens | Anti-CD155 [scFv3] |
| Tumor Marker Antigens | Anti-CD155 [SKII.4] |
| Tumor Marker Antigens | Anti-CD19 [B4] |
| Tumor Marker Antigens | Anti-CD30 [AC10 (Brentuximab)] |
| Tumor Marker Antigens | Anti-CD30 [T105] |
| Tumor Marker Antigens | Anti-CD30 [T25] |
| Tumor Marker Antigens | Anti-CD30 [T408] |
| Tumor Marker Antigens | Anti-CD30 [T6] |
| Tumor Marker Antigens | Anti-CD9 [10E4] |
| Tumor Marker Antigens | Anti-CD9 [Nb16-17] |
| Tumor Marker Antigens | Anti-CEA [BW431/26] |
| Tumor Marker Antigens | Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] |
| Tumor Marker Antigens | Anti-CEA [EB-011] |
| Tumor Marker Antigens | Anti-CEA [EB-022] |
| Tumor Marker Antigens | Anti-CEA [T84.66] |
| Tumor Marker Antigens | Anti-CIP2A [HL1925] |
| Tumor Marker Antigens | Anti-CSAp [Mu-9] |
| Tumor Marker Antigens | Anti-Ctip2 [25B6] |
| Tumor Marker Antigens | Anti-Cytokeratin 7 [OV-TL 12/30] |
| Tumor Marker Antigens | Anti-Cytokeratin 8 [TS1] |
| Tumor Marker Antigens | Anti-deltaEGFR [DH8.3] |
| Tumor Marker Antigens | Anti-EGFR [2F8 (Zalutumumab; HuMax-EGFR)] |
| Tumor Marker Antigens | Anti-EGFR [2224] |
| Tumor Marker Antigens | Anti-EGFR [528] |
| Tumor Marker Antigens | Anti-EGFR [C225 (Cetuximab)] |
| Tumor Marker Antigens | Anti-EGFR [cet.Hum (Cetuximab - humanized; hC225)] |
| Tumor Marker Antigens | Anti-EGFR [EGFR1] |
| Tumor Marker Antigens | Anti-EGFR [L2 1C] |
| Tumor Marker Antigens | Anti-EGFR [L3 11D] |
| Tumor Marker Antigens | Anti-EGFR [Matuzumab] |
| Tumor Marker Antigens | Anti-EGFR [S3 12D] |
| Tumor Marker Antigens | Anti-EGFR [S4 10H] |
| Tumor Marker Antigens | Anti-EGFR domain III [h-R3 (Nimotuzumab)] |
| Tumor Marker Antigens | Anti-EGFRvIII [L8A4] |
| Tumor Marker Antigens | Anti-Endosialin [scFv78] |
| Tumor Marker Antigens | Anti-EPCAM [B38.1] |
| Tumor Marker Antigens | Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
| Tumor Marker Antigens | Anti-ERBB2 [SAIC-02A-7] |
| Tumor Marker Antigens | Anti-GA733-2 [FU-MK-1] |
| Tumor Marker Antigens | Anti-GDF15 [Clone 29] |
| Tumor Marker Antigens | Anti-GDF15 [MBM-12] |
| Tumor Marker Antigens | Anti-GDF15 [MBM-14] |
| Tumor Marker Antigens | Anti-Glypican-1 [AbAb-GPC1] |
| Tumor Marker Antigens | Anti-Glypican-1 [AbAb2-GPC1] |
| Tumor Marker Antigens | Anti-HER2 [4D5] |
| Tumor Marker Antigens | Anti-HER2 [C7b] |
| Tumor Marker Antigens | Anti-HER2 [ML3-9 (C6ML3-9)] |
| Tumor Marker Antigens | Anti-HER2/neu [SER4] |
| Tumor Marker Antigens | Anti-HER3 [A5 ] |
| Tumor Marker Antigens | Anti-HER4 [B6 (HER4.B6)] |
| Tumor Marker Antigens | Anti-high MWT epithelial antigens [KC4G3] |
| Tumor Marker Antigens | Anti-Human Ephrin Type A receptor 2 [1C1] |
| Tumor Marker Antigens | Anti-IGFBP10 [093G9] |
| Tumor Marker Antigens | Anti-IGFBP7 [4.43] |
| Tumor Marker Antigens | Anti-JAM-A [6F4] |
| Tumor Marker Antigens | Anti-KRAS G12D mutant [D113] |
| Tumor Marker Antigens | Anti-Lewis Y [3S193] |
| Tumor Marker Antigens | Anti-LeY [BR96] |
| Tumor Marker Antigens | Anti-LeY [H18A] |
| Tumor Marker Antigens | Anti-LMP1 [H3] |
| Tumor Marker Antigens | Anti-m5C [FMC-9] |
| Tumor Marker Antigens | Anti-MAGEA3 [21B4] |
| Tumor Marker Antigens | Anti-Mesothelin [11-25] |
| Tumor Marker Antigens | Anti-Mesothelin [C10] |
| Tumor Marker Antigens | Anti-Mesothelin [IC14-30] |
| Tumor Marker Antigens | Anti-Mesothelin [K1] |
| Tumor Marker Antigens | Anti-MPF [20-10] |
| Tumor Marker Antigens | Anti-MPF [41-28] |
| Tumor Marker Antigens | Anti-MUC1 [E29] |
| Tumor Marker Antigens | Anti-MUC1 [HMFG1 (1.10.F3)] |
| Tumor Marker Antigens | Anti-MUC1 [HMFG2] |
| Tumor Marker Antigens | Anti-MUC1 [Mc5] |
| Tumor Marker Antigens | Anti-MUC1 [PAM4] |
| Tumor Marker Antigens | Anti-MUC1 [SM3] |
| Tumor Marker Antigens | Anti-NSE [E1-7E2] |
| Tumor Marker Antigens | Anti-NSE [E2-4F6] |
| Tumor Marker Antigens | Anti-OA3 [OV-TL3] |
| Tumor Marker Antigens | Anti-osteosarcoma-associated cell membrane antigen [TP-1] |
| Tumor Marker Antigens | Anti-osteosarcoma-associated cell membrane antigen [TP-3] |
| Tumor Marker Antigens | Anti-p21 [Y13-238] |
| Tumor Marker Antigens | Anti-p21Ras [DWP] |
| Tumor Marker Antigens | Anti-p21Ras [KGH-R1] |
| Tumor Marker Antigens | Anti-p53 [PAb421] |
| Tumor Marker Antigens | Anti-polymorphic epithelial mucin [CTM01] |
| Tumor Marker Antigens | Anti-PSA [8G8F5] |
| Tumor Marker Antigens | Anti-PSA [scFv B8] |
| Tumor Marker Antigens | Anti-PSMA [11d1e5E10] |
| Tumor Marker Antigens | Anti-PSMA [8C12] |
| Tumor Marker Antigens | Anti-PSMA [J591] |
| Tumor Marker Antigens | Anti-PSMA [MLN591 (deJ591)] |
| Tumor Marker Antigens | Anti-PSMA [SAM103] |
| Tumor Marker Antigens | Anti-S100 [S1-61] |
| Tumor Marker Antigens | Anti-S100B [1C8] |
| Tumor Marker Antigens | Anti-Synaptophysin [SP15] |
| Tumor Marker Antigens | Anti-TAG-72 [Minretumomab (CC49 )] |
| Tumor Marker Antigens | Anti-Tenascin [I-81C6 (Neuradiab)] |
| Tumor Marker Antigens | Anti-Tn Antigen [237mAb] |
| Tumor Marker Antigens | Anti-trastuzumab (anti-idiotype) [scFv40] |
| Tumor Marker Antigens | Anti-trastuzumab (anti-idiotype) [scFv69] |
| Tumor Marker Antigens | Anti-TRP-1, gp75 [TA99] |
| Tumor Marker Antigens | Anti-Tumor associated glycoprotein (TAG) 72 [B72.3 (Satumomab)] |
| Tumor Marker Antigens | Anti-VAP-1 [2D10] |
| Tumor Marker Antigens | Anti-VAP-1 [3F10] |
| Tumor Marker Antigens | Anti-VAP-1 [3G6] |
| Tumor Marker Antigens | Anti-VAP-1 [TK8-14] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgG [17F12] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgG [8E11] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgG [8F1] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgG [NH3/130.5.2] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgG3 [NH3/15.8] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgM [M15/8] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgE [huMaE11 (Omalizumab)] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgE [TES-C21] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgD [IgD26] |
| Anti-Human Immunoglobulin Antibodies | Anti-Lambda light chain [N10/2] |
| Anti-Human Immunoglobulin Antibodies | Anti-Kappa light chain [NH3/41.34] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgA [H15A43] |
| Anti-Human Immunoglobulin Antibodies | Anti-IgM [B481] |
| Anti-Human Immunoglobulin Antibodies | Anti-human immunoglobulin [X1237M] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Macaque pan-species IgG [1B3] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Pan-primate IgG [8F1] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Rhesus IgA alpha chain [10F12] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Marmoset IgG [4H12] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Baboon IgG1 [7H4.G8.G10] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Baboon IgG2 [1E11.1] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Baboon IgG3 [4A6.1] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Baboon IgG4 [5F3.E11.G4] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Rhesus IgG1 [3C10.3] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Rhesus IgG4 [2C6] |
| Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies | Anti-Rhesus IgG4 [7A8] |
| Other Secondary Antibodies | Anti-Rat antibody kappa light chains [OX-12] |
| Other Secondary Antibodies | Anti-Mouse antibody kappa light chain [OX-20] |
| Other Secondary Antibodies | Anti-Rat IgG [OX-59] |
| Other Secondary Antibodies | Anti-IgG [GT175] |
| Other Secondary Antibodies | Anti-IgE [R1E4] |
| Other Secondary Antibodies | Anti-IgE [mAbA9] |
| Other Secondary Antibodies | Anti-Fab [TP896] |
| Other Secondary Antibodies | Anti-Fc [TP897] |
| Other Secondary Antibodies | Anti-Fab (kappa) [TP1170] |
| Other Secondary Antibodies | Anti-Fab (kappa) [TP975] |
| Other Secondary Antibodies | Anti-Fab (lambda) [TP1014] |
| Other Secondary Antibodies | Anti-IgG1 Fc [TP1107] |
| Other Secondary Antibodies | Anti-IgG1 Fc [TP878] |
| Other Secondary Antibodies | Anti-IgG1 Fc [TP879] |
| Other Secondary Antibodies | Anti-IgG1 Fc [TP1104] |
| Other Secondary Antibodies | Anti-IgG1 Fc [TP881] |
| Other Secondary Antibodies | Anti-IgG1 Fc [TP882] |
| Other Secondary Antibodies | Anti-IgG1 Fc [TP883] |
| Other Secondary Antibodies | Anti-IgG1 Fc [TP884] |
| Other Secondary Antibodies | Anti-IgG1 Fc [TP894] |
| Other Secondary Antibodies | Anti-IgG1 Fc [TP895] |
| Other Secondary Antibodies | Anti-IgG1 (hinge) [TP885] |
| Other Secondary Antibodies | Anti-IgG1 Fab (k+l) [TP886] |
| Other Secondary Antibodies | Anti-IgG1/2a Fab (k) [TP887] |
| Other Secondary Antibodies | Anti-IgG1/2a Fab (k) [TP888] |
| Other Secondary Antibodies | Anti-IgG1/2a Fab (k) [TP889] |
| Other Secondary Antibodies | Anti-IgG1/2a Fab (k) [TP890] |
| Other Secondary Antibodies | Anti-IgG1/2a/2b Fab (k) [TP1106] |
| Other Secondary Antibodies | Anti-IgG2a Fc [TP1129] |
| Other Secondary Antibodies | Anti-IgG2a Fc [TP922] |
| Other Secondary Antibodies | Anti-IgG2a Fc [TP923] |
| Other Secondary Antibodies | Anti-IgG2a (hinge) [TP926] |
| Other Secondary Antibodies | Anti-IgG2a/2b Fc [TP925] |
| Other Secondary Antibodies | Anti-IgG2b Fab [TP979] |
| Other Secondary Antibodies | Anti-IgG2b Fab [TP984] |
| Other Secondary Antibodies | Anti-IgG3 Fc [TP924] |
| Other Secondary Antibodies | Anti-IgG2a/3 Fc [TP929] |
| Other Secondary Antibodies | Anti-IgNAR [GA8] |
| Other Secondary Antibodies | Anti-IgE [D9#3116] |
| Other Secondary Antibodies | Anti-IgM [1.14] |
| Other Secondary Antibodies | Anti-chicken IgY [IgY 176] |
| Other Secondary Antibodies | Anti-kappa light chain [4-B10] |
| Other Secondary Antibodies | Anti-kappa light chain [4-E3] |
| Other Secondary Antibodies | Anti-lambda light chain [4-D11] |
| Other Secondary Antibodies | Anti-lambda light chain [6-H5] |
| Other Secondary Antibodies | Anti-lambda light chain [8-H9] |
| Other Secondary Antibodies | Anti-immunoglobulin [6-B5] |
| Other Secondary Antibodies | Anti-antibody heavy chain [6-B7] |
| Other Secondary Antibodies | Anti-antibody heavy chain [11-E3] |
| Other Secondary Antibodies | Anti-loggehead IgY heavy chain [LH-12-4] |
| Other Secondary Antibodies | Anti-loggerhead IgY light chain [LH9] |
| Other Secondary Antibodies | Anti-loggerhead IgY spliced chain [LH1] |
| Other Secondary Antibodies | Anti-IgD (Igh-Ca haplotype) [AMS9- 9.1.1.1] |
| Other Secondary Antibodies | Anti-IgM (Igh-Cb and related haplotypes) [AF6-78.25.4] |
| Other Secondary Antibodies | Anti-Rabbit IgG [A10B] |
| Veterinary IgE Fc Proteins | Recombinant Human IgE-Fc domain |
| Veterinary IgE Fc Proteins | Recombinant Mouse IgE-Fc domain |
| Veterinary IgE Fc Proteins | Recombinant Dog IgE-Fc domain |
| Veterinary IgE Fc Proteins | Recombinant Cat IgE-Fc domain |
| Veterinary IgE Fc Proteins | Recombinant HorseIg E-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant HumanIgG1-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant HumanIgG2-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant HumanIgG3-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant HumanIgG4-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant MouseIgG1-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant MouseIgG2A-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant HumanIgE-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant HumanIgA-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant MouseIgE-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant Human LMW IgM-Fc domain(monomeric) |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant Dog IgE-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant Cat IgE-Fc domain |
| Immunoglobulin Fc domains (Ig Fc domains) | Recombinant Horse IgE-Fc domain |
| Recombinant Free Light Chains | Recombinant Human Free Kappa Light Chain |
| Recombinant Free Light Chains | Recombinant Human Free Lambda Light Chain |
| Fc Fusion Proteins | Recombinant humanNR3L1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanFCRL6 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanBY55 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanTIMG2 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanTMM81 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanNCAM1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanLINGO2 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanLAIR2 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanLAIR1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanHAVCR1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanCADM1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanAMIGO3 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanCD70 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouse4-1BB Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseTL1A Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseCD155 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseCD96 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseTIM-3 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseTIM-1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseCD86 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseCD80 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseBTLA Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseHVEM Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseCD52-Fc Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseFc-CD52 Fusion Protein |
| Fc Fusion Proteins | Recombinant humanSLAF6 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanTNR4 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanCD69 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanSEM4D Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanNKG2-F Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanTNR9 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanCEACAM1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanSLAF7 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanCD27 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseVISTA Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseTIGIT Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseLag3 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseCD70 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseCD27 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouse4-1BBL Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseB7-H3 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseICOSL Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mousePDL2 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseCTLA4 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseOX40 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseICOS Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mousePD-1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanCTLA-4 Fc-Fusion Protein (Abatacept) |
| Fc Fusion Proteins | Recombinant humanTNFR1B Fc-Fusion Protein (Etanercept) |
| Fc Fusion Proteins | Recombinant humanNKG2E Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanNCTR1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanNCTR3 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanNKG2D Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanCD96 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanCD226 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanTIGIT Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant humanEGFR Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseCD47 (C33 to G mutation) Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mousePDL1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseTNFR1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant mouseIL2 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant HumanCTLA-4 Fc Silent™-Fusion Protein |
| Fc Fusion Proteins | Recombinant HumanCTLA-4 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant HumanACE2-IgG Fc (LALA)-Fusion Protein |
| Fc Fusion Proteins | Recombinant HumanACE2-NN-IgG Fc (LALA)-Fusion Protein |
| Fc Fusion Proteins | Recombinant S1-camel Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant IL-13 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant CD40 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant CD40 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant CD40 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant PD1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant PDL1 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant ICOS Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant CTLA4 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant IL-4 Fc-Fusion Protein |
| Fc Fusion Proteins | Recombinant NK1.1 Fc-Fusion Protein |
| Multi-Tag Control Proteins | Multi-Tag Control Protein |
| Multi-Tag Control Proteins | Multi-Tag Control Protein 2 |